Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Stilonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 19/20 | 1.00 |
| ▸ | CHRNB4 | P30926 | 10/20 | 1.00 |
| ▸ | CHRNA3 | P32297 | 10/20 | 1.00 |
| ▸ | CHRNA10 | Q9GZZ6 | 5/20 | 1.00 |
| ▸ | CHRNA9 | Q9UGM1 | 5/20 | 1.00 |
| ▸ | CHRNB2 | P17787 | 4/20 | 1.00 |
| ▸ | CHRNA4 | P43681 | 4/20 | 1.00 |
| ▸ | APOBEC3A | P31941 | 1/20 | 1.00 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 1.00 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 0.97 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.97 |
| ▸ | MEN1 | O00255 | 1/20 | 0.97 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.97 |
| ▸ | TP53 | P04637 | 1/20 | 0.97 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.97 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.97 |
| ▸ | HPGD | P15428 | 1/20 | 0.97 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.97 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.97 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Stilonium SCHEMBL26104 | 1.00 | CHRNA7 (1.00) | CHRNA7CHRNB4CHRNA3CHRNA10CHRNA9 | |
| Stilonium SCHEMBL10197132 | 0.98 | CHRNA7 (1.00) | CHRNA7CHRNB4CHRNA3CHRNA10CHRNA9 | |
| SCHEMBL13385235 | 0.83 | CHRNA7 (1.00) | CHRNA7CHRNB4CHRNA3CHRNA10CHRNA9 | |
| Hydrochloric Acid SCHEMBL11423649 | 0.81 | CHRNA7 (0.96) | CHRNA7CHRNB4CHRNA3CHRNA10CHRNA9 | |
| SCHEMBL1618632 | 0.80 | RELA (0.72) | CHRNA7CHRNB4CHRNA3CHRNA10CHRNA9 | |
| SCHEMBL5741015 | 0.80 | RELA (0.72) | CHRNA7CHRNB4CHRNA3CHRNA10CHRNA9 | |
| SCHEMBL80814 | 0.76 | CHRNA7 (0.72) | CHRNA7CHRNB4CHRNA3CHRNA10CHRNA9 | |
| SCHEMBL436231 | 0.76 | RELA (1.00) | CHRNA7CHRNB4CHRNA3CHRNA10CHRNA9 | |
| SCHEMBL5496245 | 0.76 | RELA (1.00) | CHRNA7CHRNB4CHRNA3CHRNA10CHRNA9 | |
| SCHEMBL5739190 | 0.76 | CHRNA7 (0.68) | CHRNA7CHRNB4CHRNA3CHRNA10CHRNA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 765 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250221968-A1 | TREATMENTS AND METHODS FOR INCREASING DOPAMINE | UNIV OXFORD INNOVATION LTD (GB) | 2025-07-10 | — | — | US | claimed |
| EP-4493171-A1 | NICOTINIC ACETYLCHOLINE RECEPTOR ANTAGONIST/BLOCKER FOR USE IN INCREASING DOPAMINE | Zhang, Yanfeng C/o Oxford University Innovation Limited (GB) | 2025-01-22 | — | — | EP | claimed |
| WO-2023175357-A1 | NICOTINIC ACETYLCHOLINE RECEPTOR ANTAGONIST/BLOCKER FOR USE IN INCREASING DOPAMINE | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2023-09-21 | — | — | WO | claimed |
| US-10383510-B2 | Implant with high vapor pressure medium | SOLACE THERAPEUTICS, INC. (US) | 2019-08-20 | — | — | US | claimed |
| US-8268352-B2 | Modified release composition for highly soluble drugs | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-18 | — | — | US | claimed |
| US-8263125-B2 | Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-11 | — | — | US | claimed |
| EP-2367503-A1 | IMPLANT WITH HIGH VAPOR PRESSURE MEDIUM | AttenueX Technologies, Inc. (US) | 2011-09-28 | — | — | EP | claimed |
| US-20100222802-A1 | IMPLANT WITH HIGH VAPOR PRESSURE MEDIUM | ATTENUEX TECHNOLOGIES, INC. (US) | 2010-09-02 | — | — | US | claimed |
| WO-2010068467-A1 | IMPLANT WITH HIGH VAPOR PRESSURE MEDIUM | ATTENUEX TECHNOLOGIES, INC. (US) | 2010-06-17 | — | — | WO | claimed |
| EP-1879578-A4 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE | DOV PHARMACEUTICAL INC (US) | 2009-05-13 | — | — | EP | claimed |
| EP-1879578-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE | DOV Pharmaceutical Inc. (US) | 2008-01-23 | — | — | EP | claimed |
| WO-2006102029-A9 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE | DOV PHARMACEUTICAL INC (US) | 2006-12-07 | — | — | WO | claimed |
| WO-2006102029-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE | DOV PHARMACEUTICAL, INC. (US) | 2006-09-28 | — | — | WO | claimed |
| US-20060024365-A1 | Novel dosage form | VAYA NAVIN | 2006-02-02 | — | — | US | claimed |
| US-20060018933-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| US-20060018934-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-4168092-B1 | BALLOON CATHETER WITH PRECISION DRUG-ELUTING CAPABILITY | BARD INC C R (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-4744688-A2 | DRUG DELIVERY DEVICES WITH DRUG-PERMEABLE COMPONENT AND METHODS | Janssen Biotech, Inc. (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-3285850-B1 | DRUG DELIVERY DEVICES WITH DRUG-PERMEABLE COMPONENT AND METHOD OF MANUFACTURING | JANSSEN BIOTECH INC (US) | 2026-05-06 | — | — | EP | disclosed |
| US-20260097102-A1 | Treatment Of Respiratory Disorders With Arachidonate 15-Lipoxygenase (ALOX15) Inhibitors | REGENERON PHARMA (US) | 2026-04-09 | — | — | US | disclosed |
| US-12576253-B2 | Drug delivery device with intravesical tolerability | TARIS BIOMEDICAL LLC (US) | 2026-03-17 | — | — | US | disclosed |
| EP-4706683-A2 | CHEWABLE FORMULATIONS | Elanco Tiergesundheit AG (CH) | 2026-03-11 | — | — | EP | disclosed |
| EP-3799862-B1 | IMPLANTABLE UROLOGICAL DEVICE WITH RETRIEVAL FEATURE | TARIS BIOMEDICAL LLC (US) | 2026-02-18 | — | — | EP | disclosed |
| US-20260034059-A1 | ORAL FILM COMPOSITIONS AND DOSAGE FORMS HAVING PRECISE ACTIVE DISSOLUTION PROFILES | AQUESTIVE THERAPEUTICS, INC. (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260021224-A1 | Multi-Unit Drug Delivery Devices and Methods | JANSSEN BIOTECH, INC. | 2026-01-22 | — | — | US | disclosed |
| US-20250381375-A1 | Drug Delivery Device with Drug-Permeable Component | JANSSEN BIOTECH, INC. | 2025-12-18 | — | — | US | disclosed |
| US-12478768-B2 | Ultrasonic urinary bladder drug delivery | VENSICA MEDICAL LTD. (IL) | 2025-11-25 | — | — | US | disclosed |
| US-12472241-B2 | Treatment of respiratory disorders with arachidonate 15-lipoxygenase (ALOX15) inhibitors | REGENERON PHARMACEUTICALS, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| US-12465564-B2 | Oral and nasal compositions and methods of treatment | AQUESTIVE THERAPEUTICS, INC. (US) | 2025-11-11 | — | — | US | disclosed |
| US-20250339367-A1 | ORAL FILM COMPOSITIONS AND DOSAGE FORMS HAVING PRECISE ACTIVE DISSOLUTION PROFILES | AQUESTIVE THERAPEUTICS, INC. (US) | 2025-11-06 | — | — | US | disclosed |
| US-12458392-B2 | Scoring balloon with translating scoring wires | C.R. BARD, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| US-12447241-B2 | Multi-unit drug delivery devices and methods | TARIS BIOMEDICAL LLC (US) | 2025-10-21 | — | — | US | disclosed |
| US-12409304-B2 | Drug delivery devices with drug-permeable component and methods | TARIS BIOMEDICAL LLC (US) | 2025-09-09 | — | — | US | disclosed |
| US-12403090-B2 | Oral film compositions and dosage forms having precise active dissolution profiles | AQUESTIVE THERAPEUTICS, INC. (US) | 2025-09-02 | — | — | US | disclosed |
| US-12403086-B2 | Solid drug tablets for implantable drug delivery devices | TARIS BIOMEDICAL LLC (US) | 2025-09-02 | — | — | US | disclosed |
| US-20250255780-A1 | SYSTEM AND METHOD FOR MAKING PERSONALIZED INDIVIDUAL UNIT DOSES CONTAINING PHARMACEUTICAL ACTIVES | AQUESTIVE THERAPEUTICS, INC. (US) | 2025-08-14 | — | — | US | disclosed |
| US-20250221968-A1 | TREATMENTS AND METHODS FOR INCREASING DOPAMINE | UNIV OXFORD INNOVATION LTD (GB) | 2025-07-10 | — | — | US | disclosed |
| EP-3884988-B1 | IMPLANTABLE DEVICE WITH INTRAVESICAL TOLERABILITY | TARIS BIOMEDICAL LLC (US) | 2025-06-18 | — | — | EP | disclosed |
| EP-4570239-A2 | DRUG DELIVERY DEVICES WITH DRUG-PERMEABLE COMPONENT | TARIS Biomedical LLC (US) | 2025-06-18 | — | — | EP | disclosed |
| US-12310922-B2 | System and method for making personalized individual unit doses containing pharmaceutical actives | AQUESTIVE THERAPEUTICS, INC. (US) | 2025-05-27 | — | — | US | disclosed |
| US-12296127-B2 | Intravesical drug delivery devices | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-05-13 | — | — | US | disclosed |
| US-12290597-B2 | Oral film compositions and dosage forms having precise active dissolution profiles | AQUESTIVE THERAPEUTICS, INC. (US) | 2025-05-06 | — | — | US | disclosed |
| EP-2968880-B1 | DRUG DELIVERY DEVICES WITH DRUG-PERMEABLE COMPONENT | TARIS BIOMEDICAL LLC (US) | 2025-04-30 | — | — | EP | disclosed |
| US-12263244-B2 | Intravesical device for controlled drug delivery | TARIS BIOMEDICAL LLC (US) | 2025-04-01 | — | — | US | disclosed |
| US-12239807-B2 | Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems | TARIS BIOMEDICAL LLC (US) | 2025-03-04 | — | — | US | disclosed |
| EP-4193939-B1 | ULTRASONIC URINARY BLADDER DRUG DELIVERY | VENSICA MEDICAL LTD (IL) | 2025-02-26 | — | — | EP | disclosed |
| EP-3799863-B1 | IMPLANTABLE UROLOGICAL DEVICE WITH RETRIEVAL FEATURE | TARIS BIOMEDICAL LLC (US) | 2025-02-12 | — | — | EP | disclosed |
| US-12214148-B2 | Multi-lumen drug delivery devices and methods | TARIS BIOMEDICAL LLC (US) | 2025-02-04 | — | — | US | disclosed |
| EP-4493171-A1 | NICOTINIC ACETYLCHOLINE RECEPTOR ANTAGONIST/BLOCKER FOR USE IN INCREASING DOPAMINE | Zhang, Yanfeng C/o Oxford University Innovation Limited (GB) | 2025-01-22 | — | — | EP | disclosed |
| US-20240424269-A1 | Drug Delivery Devices and Methods for Drug Delivery | JANSSEN BIOTECH, INC. | 2024-12-26 | — | — | US | disclosed |
| US-12171723-B2 | System and method for making personalized individual unit doses containing pharmaceutical actives | AQUESTIVE THERAPEUTICS, INC. (US) | 2024-12-24 | — | — | US | disclosed |
| US-12167883-B2 | Medical device including expandable muscle polymer | BARD PERIPHERAL VASCULAR, INC. (US) | 2024-12-17 | — | — | US | disclosed |
| US-12090292-B2 | Drug delivery devices and methods for drug delivery | TARIS BIOMEDICAL LLC (US) | 2024-09-17 | — | — | US | disclosed |
| EP-4422607-A1 | ORAL AND NASAL COMPOSITIONS AND METHODS OF TREATMENT | Aquestive Therapeutics, Inc. (US) | 2024-09-04 | — | — | EP | disclosed |
| US-20240198067-A1 | Drug Delivery Device with Intravesical Tolerability | LIRIS BIOMEDICAL, INC. | 2024-06-20 | — | — | US | disclosed |
| US-11992583-B2 | Drug delivery devices and methods | TARIS BIOMEDICAL LLC (US) | 2024-05-28 | — | — | US | disclosed |
| EP-4210606-B1 | MEDICAL DEVICE INCLUDING EXPANDABLE MUSCLE POLYMER | BARD PERIPHERAL VASCULAR INC (US) | 2024-05-01 | — | — | EP | disclosed |
| EP-3970643-B1 | SCORING BALLOON WITH TRANSLATING SCORING WIRES | BARD INC C R (US) | 2024-04-17 | — | — | EP | disclosed |
| US-20240091136-A1 | Solid Drug Tablets for Implantable Drug Delivery Devices | JANSSEN BIOTECH, INC. | 2024-03-21 | — | — | US | disclosed |
| US-11918447-B2 | Systems, methods and devices relating to implantable supportive slings | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-03-05 | — | — | US | disclosed |
| US-11904123-B2 | Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems | TARIS BIOMEDICAL LLC (US) | 2024-02-20 | — | — | US | disclosed |
| US-20240050317-A1 | SYSTEM AND METHOD FOR MAKING PERSONALIZED INDIVIDUAL UNIT DOSES CONTAINING PHARMACEUTICAL ACTIVES | AQUESTIVE THERAPEUTICS, INC. (US) | 2024-02-15 | — | — | US | disclosed |
| US-11890439-B2 | Drug delivery device with intravesical tolerability | TARIS BIOMEDICAL LLC (US) | 2024-02-06 | — | — | US | disclosed |
| US-11883272-B2 | Tension-adjustable surgical sling assembly | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-01-30 | — | — | US | disclosed |
| EP-4304554-A1 | DOSAGE FORMS HAVING EQUIVALENT BIOCOMPARABLE PROFILES | Aquestive Therapeutics, Inc. (US) | 2024-01-17 | — | — | EP | disclosed |
| US-20230414452-A1 | SYSTEM AND METHOD FOR MAKING PERSONALIZED INDIVIDUAL UNIT DOSES CONTAINING PHARMACEUTICAL ACTIVES | AQUESTIVE THERAPEUTICS, INC. (US) | 2023-12-28 | — | — | US | disclosed |
| US-20230405292-A1 | Drug Delivery Devices with Drug-Permeable Component and Methods | JANSSEN BIOTECH, INC. | 2023-12-21 | — | — | US | disclosed |
| US-11844856-B2 | Solid drug tablets for implantable drug delivery devices | TARIS BIOMEDICAL LLC (US) | 2023-12-19 | — | — | US | disclosed |
| US-20230389955-A1 | Scoring Balloon With Translating Scoring Wires | BARD INC C R (US) | 2023-12-07 | — | — | US | disclosed |
| EP-4277611-A1 | PRODRUG COMPOSITIONS AND METHODS OF TREATMENT | Aquestive Therapeutics, Inc. (US) | 2023-11-22 | — | — | EP | disclosed |
| US-11806311-B2 | System and method for making personalized individual unit doses containing pharmaceutical actives | AQUESTIVE THERAPEUTICS, INC. (US) | 2023-11-07 | — | — | US | disclosed |
| US-11771457-B2 | Scoring balloon with translating scoring wires | C.R. BARD, INC. (US) | 2023-10-03 | — | — | US | disclosed |
| WO-2023175357-A1 | NICOTINIC ACETYLCHOLINE RECEPTOR ANTAGONIST/BLOCKER FOR USE IN INCREASING DOPAMINE | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2023-09-21 | — | — | WO | disclosed |
| US-20230295617-A1 | METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS | WAVE LIFE SCIENCES LTD. (SG) | 2023-09-21 | — | — | US | disclosed |
| US-20230277448-A1 | CHEWABLE FORMULATIONS | ELANCO TIERGESUNDHEIT AG (CH) | 2023-09-07 | — | — | US | disclosed |
| US-11744998-B2 | Drug delivery devices with drug-permeable component and methods | TARIS BIOMEDICAL LLC (US) | 2023-09-05 | — | — | US | disclosed |
| EP-4234036-A2 | MULTI-UNIT DRUG DELIVERY DEVICES | TARIS Biomedical LLC (US) | 2023-08-30 | — | — | EP | disclosed |
| US-20230256212-A1 | BALLOON CATHETER WITH PRECISION DRUG-ELUTING CAPABILITY | C.R. BARD, INC. | 2023-08-17 | — | — | US | disclosed |
| US-20230255879-A1 | METHODS AND SYSTEMS FOR ASSEMBLING INTRAVESICAL DRUG DELIVERY DEVICES | JANSSEN BIOTECH, INC. | 2023-08-17 | — | — | US | disclosed |
| US-20230240739-A1 | MEDICAL DEVICE INCLUDING EXPANDABLE MUSCLE POLYMER | BARD PERIPHERAL VASCULAR, INC. | 2023-08-03 | — | — | US | disclosed |
| EP-3884886-B1 | SCORING BALLOON WITH TRANSLATING SCORING WIRES | BARD INC C R (US) | 2023-08-02 | — | — | EP | disclosed |
| US-20230226314-A1 | Intravesical Drug Delivery Devices | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2023-07-20 | — | — | US | disclosed |
| EP-4210606-A1 | MEDICAL DEVICE INCLUDING EXPANDABLE MUSCLE POLYMER | Bard Peripheral Vascular, Inc. (US) | 2023-07-19 | — | — | EP | disclosed |
| EP-4208155-A1 | CHEWABLE FORMULATIONS | Elanco Tiergesundheit AG (CH) | 2023-07-12 | — | — | EP | disclosed |
| EP-3736015-B1 | MULTI-UNIT DRUG DELIVERY DEVICES | TARIS BIOMEDICAL LLC (US) | 2023-06-28 | — | — | EP | disclosed |
| EP-4193939-A1 | ULTRASONIC URINARY BLADDER DRUG DELIVERY | Vensica Medical Ltd. (IL) | 2023-06-14 | — | — | EP | disclosed |
| US-20230149304-A1 | ORAL FILM COMPOSITIONS AND DOSAGE FORMS HAVING PRECISE ACTIVE DISSOLUTION PROFILES | AQUESTIVE THERAPEUTICS, INC. (US) | 2023-05-18 | — | — | US | disclosed |
| US-20230145752-A1 | ORAL FILM COMPOSITIONS AND DOSAGE FORMS HAVING PRECISE ACTIVE DISSOLUTION PROFILES | AQUESTIVE THERAPEUTICS, INC. (US) | 2023-05-11 | — | — | US | disclosed |
| WO-2023076281-A1 | ORAL AND NASAL COMPOSITIONS AND METHODS OF TREATMENT | AQUESTIVE THERAPEUTICS, INC. (US) | 2023-05-04 | — | — | WO | disclosed |
| EP-4173615-A2 | INTRAVESICAL DRUG DELIVERY DEVICES AND METHODS INCLUDING ELASTIC POLYMER-DRUG MATRIX SYSTEMS | TARIS Biomedical LLC (US) | 2023-05-03 | — | — | EP | disclosed |
| US-20230131450-A1 | ORAL AND NASAL COMPOSITIONS AND METHODS OF TREATMENT | AQUESTIVE THERAPEUTICS, INC. (US) | 2023-04-27 | — | — | US | disclosed |
| EP-4168092-A1 | BALLOON CATHETER WITH PRECISION DRUG-ELUTING CAPABILITY | C. R. Bard, Inc. (US) | 2023-04-26 | — | — | EP | disclosed |
| US-11612718-B2 | Intravesical drug delivery devices | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-03-28 | — | — | US | disclosed |
| US-11596595-B2 | Intravesical drug delivery device with retention frame and drug tablets | TARIS BIOMEDICAL LLC (US) | 2023-03-07 | — | — | US | disclosed |
| EP-3274044-B1 | ULTRASONIC URINARY BLADDER DRUG DELIVERY | VENSICA MEDICAL LTD (IL) | 2023-03-01 | — | — | EP | disclosed |
| US-20230059204-A1 | TRANSDERMAL MICRO-DOSING DELIVERY OF PHARMACEUTICAL AGENTS | Pike Therapeutics Inc. (CA) | 2023-02-23 | — | — | US | disclosed |
| EP-4135712-A1 | TRANSDERMAL MICRO-DOSING DELIVERY OF PSYCHEDELICS DERIVATIVES | Pike Therapeutics, Inc. (CA) | 2023-02-22 | — | — | EP | disclosed |
| WO-2023012691-A1 | TRANSDERMAL MICRO-DOSING DELIVERY OF PHARMACEUTICAL AGENTS | PIKE THERAPEUTICS, INC. (CA) | 2023-02-09 | — | — | WO | disclosed |
| US-20230015383-A1 | ULTRASONIC URINARY BLADDER DRUG DELIVERY | VENSICA MEDICAL LTD. (IL) | 2023-01-19 | — | — | US | disclosed |
| CN-115605254-A | Balloon catheter with precise drug elution capability | 巴德股份有限公司（US） | 2023-01-13 | — | — | CN | disclosed |
| US-11541002-B2 | Oral film compositions and dosage forms having precise active dissolution profiles | AQUESTIVE THERAPEUTICS, INC. (US) | 2023-01-03 | — | — | US | disclosed |
| EP-3517099-B1 | INTRAVESICAL DRUG DELIVERY DEVICES AND METHODS INCLUDING ELASTIC POLYMER-DRUG MATRIX SYSTEMS | TARIS BIOMEDICAL LLC (US) | 2022-12-28 | — | — | EP | disclosed |
| CN-112169134-B | Implantable urological device with improved retrieval features | 塔里斯生物医药公司 | 2022-11-29 | — | — | CN | disclosed |
| US-20220347117-A1 | DOSAGE FORMS HAVING EQUIVALENT BIOCOMPARABLE PROFILES | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION | 2022-11-03 | — | — | US | disclosed |
| US-11478618-B2 | Ultrasonic urinary bladder drug delivery | VENSICA MEDICAL LTD. (IL) | 2022-10-25 | — | — | US | disclosed |
| EP-4058029-A1 | MULTIMODAL COMPOSITIONS AND METHODS OF TREATMENT | Aquestive Therapeutics, Inc. (US) | 2022-09-21 | — | — | EP | disclosed |
| WO-2022192476-A1 | DOSAGE FORMS HAVING EQUIVALENT BIOCOMPARABLE PROFILES | AQUESTIVE THERAPEUTICS, INC. (US) | 2022-09-15 | — | — | WO | disclosed |
| WO-2022187556-A1 | THERAPEUTIC METHODS AND COMPOSITIONS COMPRISING MAGNETIZABLE NANOPARTICLES | VRG STEM CELL SERVICES INC. (US) | 2022-09-09 | — | — | WO | disclosed |
| EP-4051235-A1 | PRODRUG COMPOSITIONS AND METHODS OF TREATMENT | Aquestive Therapeutics, Inc. (US) | 2022-09-07 | — | — | EP | disclosed |
| US-20220257280-A1 | SCORING BALLOON WITH TRANSLATING SCORING WIRES | BARD INC C R (US) | 2022-08-18 | — | — | US | disclosed |
| US-11406417-B2 | Scoring balloon with translating scoring wires | C.R. BARD, INC. (US) | 2022-08-09 | — | — | US | disclosed |
| US-20220233471-A1 | PRODRUG COMPOSITIONS AND METHODS OF TREATMENT | AQUESTIVE THERAPEUTICS, INC. (US) | 2022-07-28 | — | — | US | disclosed |
| WO-2022155544-A1 | PRODRUG COMPOSITIONS AND METHODS OF TREATMENT | AQUESTIVE THERAPEUTICS, INC. (US) | 2022-07-21 | — | — | WO | disclosed |
| US-20220211987-A1 | DRUG DELIVERY DEVICES WITH DRUG-PERMEABLE COMPONENT AND METHODS | JANSSEN BIOTECH, INC. | 2022-07-07 | — | — | US | disclosed |
| US-11357651-B2 | Stent assembly and method of preparing the stent assembly | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2022-06-14 | — | — | US | disclosed |
| US-11285304-B2 | Drug delivery devices with drug-permeable component and methods | TARIS BIOMEDICAL LLC (US) | 2022-03-29 | — | — | US | disclosed |
| EP-3970643-A1 | SCORING BALLOON WITH TRANSLATING SCORING WIRES | C.R. Bard, Inc. (US) | 2022-03-23 | — | — | EP | disclosed |
| WO-2022055491-A1 | MEDICAL DEVICE INCLUDING EXPANDABLE MUSCLE POLYMER | BARD PERIPHERAL VASCULAR, INC. (US) | 2022-03-17 | — | — | WO | disclosed |
| WO-2022049149-A1 | CHEWABLE FORMULATIONS | ELANCO TIERGESUNDHEIT AG (CH) | 2022-03-10 | — | — | WO | disclosed |
| US-20220040461-A1 | MULTI-LUMEN DRUG DELIVERY DEVICES AND METHODS | TARIS BIOMEDICAL LLC | 2022-02-10 | — | — | US | disclosed |
| WO-2021262134-A1 | BALLOON CATHETER WITH PRECISION DRUG-ELUTING CAPABILITY | C.R. BARD, INC. (US) | 2021-12-30 | — | — | WO | disclosed |
| US-20210401741-A1 | Intravesical Device for Controlled Drug Delivery | LIRIS BIOMEDICAL, INC. | 2021-12-30 | — | — | US | disclosed |
| US-11185670-B2 | Multi-lumen drug delivery devices | TARIS BIOMEDICAL LLC (US) | 2021-11-30 | — | — | US | disclosed |
| EP-2881082-B1 | Systems and devices for treating pelvic floor disorders | BOSTON SCIENT LTD (BM) | 2021-11-24 | — | — | EP | disclosed |
| EP-3902567-A2 | TREATMENT OF RESPIRATORY DISORDERS WITH ARACHIDONATE15-LIPOXYGENASE (ALOX15) INHIBITORS | Regeneron Pharmaceuticals, Inc. (US) | 2021-11-03 | — | — | EP | disclosed |
| EP-3562416-B1 | SCORING BALLOON WITH TRANSLATING SCORING WIRES | BARD INC C R (US) | 2021-10-27 | — | — | EP | disclosed |
| US-20210322447-A1 | TRANSDERMAL MICRO-DOSING DELIVERY OF PSYCHEDELICS DERIVATIVES | PIKE THERAPEUTICS INC (CA) | 2021-10-21 | — | — | US | disclosed |
| WO-2021209815-A1 | TRANSDERMAL MICRO-DOSING DELIVERY OF PSYCHEDELICS DERIVATIVES | PIKE THERAPEUTICS, INC. (CA) | 2021-10-21 | — | — | WO | disclosed |
| US-20210308039-A1 | SOLID DRUG TABLETS FOR IMPLANTABLE DRUG DELIVERY DEVICES | JANSSEN BIOTECH, INC. | 2021-10-07 | — | — | US | disclosed |
| US-11135161-B2 | Intravesical device for controlled drug delivery | TARIS BIOMEDICAL LLP (US) | 2021-10-05 | — | — | US | disclosed |
| EP-3884886-A1 | SCORING BALLOON WITH TRANSLATING SCORING WIRES | C.R. Bard, Inc. (US) | 2021-09-29 | — | — | EP | disclosed |
| EP-3884988-A1 | IMPLANTABLE DEVICE WITH INTRAVESICAL TOLERABILITY AND METHODS OF TREATMENT | TARIS Biomedical LLC (US) | 2021-09-29 | — | — | EP | disclosed |
| US-20210290771-A1 | ENGINEERED RECEPTOR/LIGAND SYSTEM FOR DELIVERY OF THERAPEUTIC AGENTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2021-09-23 | — | — | US | disclosed |
| US-20210275789-A1 | DRUG DELIVERY DEVICES AND METHODS FOR DRUG DELIVERY | JANSSEN BIOTECH, INC. | 2021-09-09 | — | — | US | disclosed |
| US-20210252262-A1 | DRUG DELIVERY DEVICE WITH INTRAVESICAL TOLERABILITY | LIRIS BIOMEDICAL, INC. | 2021-08-19 | — | — | US | disclosed |
| US-11065426-B2 | Implantable device with intravesical tolerability and methods of treatment | TARIS BIOMEDICAL LLC (US) | 2021-07-20 | — | — | US | disclosed |
| EP-3838328-A2 | DRUG DELIVERY DEVICES | TARIS Biomedical LLC (US) | 2021-06-23 | — | — | EP | disclosed |
| US-11040005-B2 | Solid drug tablets for implantable drug delivery devices | TARIS BIOMEDICAL LLC (US) | 2021-06-22 | — | — | US | disclosed |
| US-11020575-B2 | In vivo drug delivery devices and methods for drug delivery | TARIS BIOMEDICAL LLC (US) | 2021-06-01 | — | — | US | disclosed |
| WO-2021097247-A1 | MULTIMODAL COMPOSITIONS AND METHODS OF TREATMENT | AQUESTIVE THERAPEUTICS, INC. (US) | 2021-05-20 | — | — | WO | disclosed |
| US-20210146013-A1 | DRUG DELIVERY DEVICES AND METHODS | JANSSEN BIOTECH, INC. | 2021-05-20 | — | — | US | disclosed |
| US-20210145731-A1 | MULTIMODAL COMPOSITIONS AND METHODS OF TREATMENT | AQUESTIVE THERAPEUTICS, INC. (US) | 2021-05-20 | — | — | US | disclosed |
| US-11000597-B2 | Engineered receptor/ligand system for delivery of therapeutic agents | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2021-05-11 | — | — | US | disclosed |
| WO-2021087359-A1 | PRODRUG COMPOSITIONS AND METHODS OF TREATMENT | AQUESTIVE THERAPEUTICS, INC. (US) | 2021-05-06 | — | — | WO | disclosed |
| US-20210128511-A1 | PRODRUG COMPOSITIONS AND METHODS OF TREATMENT | AQUESTIVE THERAPEUTICS, INC. (US) | 2021-05-06 | — | — | US | disclosed |
| US-20210121670-A1 | Drug Delivery Devices with Drug-Permeable Component and Methods | JANSSEN BIOTECH, INC. | 2021-04-29 | — | — | US | disclosed |
| EP-3811371-A1 | SYSTEM AND METHOD FOR MAKING PERSONALIZED INDIVIDUAL UNIT DOSES CONTAINING PHARMACEUTICAL ACTIVES | Aquestive Therapeutics, Inc. (US) | 2021-04-28 | — | — | EP | disclosed |
| EP-3799863-A1 | IMPLANTABLE UROLOGICAL DEVICE WITH RETRIEVAL FEATURE | TARIS Biomedical LLC (US) | 2021-04-07 | — | — | EP | disclosed |
| EP-3799862-A1 | IMPLANTABLE UROLOGICAL DEVICE WITH RETRIEVAL FEATURE | TARIS Biomedical LLC (US) | 2021-04-07 | — | — | EP | disclosed |
| EP-3432970-B1 | IN VIVO DRUG DELIVERY DEVICES | TARIS BIOMEDICAL LLC (US) | 2021-03-24 | — | — | EP | disclosed |
| EP-3795121-A1 | URETERAL STENT DRUG DELIVERY DEVICE | TARIS Biomedical LLC (US) | 2021-03-24 | — | — | EP | disclosed |
| EP-3560443-B1 | SCORING BALLOON WITH TRANSLATING SCORING WIRES | BARD INC C R (US) | 2021-03-10 | — | — | EP | disclosed |
| US-10933170-B2 | Drug delivery devices and methods | TARIS BIOMEDICAL LLC (US) | 2021-03-02 | — | — | US | disclosed |
| EP-2512581-B1 | IMPLANTABLE DEVICE WITH INTRAVESICAL TOLERABILITY | TARIS BIOMEDICAL LLC (US) | 2021-02-17 | — | — | EP | disclosed |
| US-10894150-B2 | Drug delivery devices with drug-permeable component and methods | TARIS BIOMEDICAL LLC (US) | 2021-01-19 | — | — | US | disclosed |
| US-20200405625-A1 | SOLID DRUG TABLETS FOR IMPLANTABLE DRUG DELIVERY DEVICES | JANSSEN BIOTECH, INC. | 2020-12-31 | — | — | US | disclosed |
| US-10857336-B2 | Implantable urological device with improved retrieval feature | TARIS BIOMEDICAL LLC (US) | 2020-12-08 | — | — | US | disclosed |
| EP-3142740-B1 | DRUG DELIVERY DEVICES | TARIS BIOMEDICAL LLC (US) | 2020-12-02 | — | — | EP | disclosed |
| US-20200368508-A1 | INTRAVESICAL DRUG DELIVERY DEVICES AND METHODS INCLUDING ELASTIC POLYMER-DRUG MATRIX SYSTEMS | JANSSEN BIOTECH, INC. | 2020-11-26 | — | — | US | disclosed |
| US-20200368509-A1 | INTRAVESICAL DRUG DELIVERY DEVICES AND METHODS INCLUDING ELASTIC POLYMER-DRUG MATRIX SYSTEMS | JANSSEN BIOTECH, INC. | 2020-11-26 | — | — | US | disclosed |
| EP-3741330-A2 | URETERAL STENT DRUG DELIVERY DEVICE | TARIS Biomedical LLC (US) | 2020-11-25 | — | — | EP | disclosed |
| EP-2849725-B1 | IMPLANTABLE UROLOGICAL DEVICE WITH IMPROVED RETRIEVAL FEATURE | TARIS BIOMEDICAL LLC (US) | 2020-11-25 | — | — | EP | disclosed |
| US-20200360574-A1 | MULTI-UNIT DRUG DELIVERY DEVICES AND METHODS | JANSSEN BIOTECH, INC. | 2020-11-19 | — | — | US | disclosed |
| US-20200353131-A1 | MULTI-UNIT DRUG DELIVERY DEVICES AND METHODS | JANSSEN BIOTECH, INC. | 2020-11-12 | — | — | US | disclosed |
| EP-3736015-A1 | MULTI-UNIT DRUG DELIVERY DEVICES AND METHODS | TARIS Biomedical LLC (US) | 2020-11-11 | — | — | EP | disclosed |
| US-20200345976-A1 | Drug Delivery Devices and Methods for Use with a Urinary Catheter | TARIS BIOMEDICAL LLC | 2020-11-05 | — | — | US | disclosed |
| US-20200345624-A1 | Nanopore Delivery Device | HUDSON LEE EDWARD (US) | 2020-11-05 | — | — | US | disclosed |
| EP-2600800-B1 | URETERAL STENT DRUG DELIVERY DEVICE AND KIT | TARIS BIOMEDICAL LLC (US) | 2020-09-30 | — | — | EP | disclosed |
| EP-3706848-A1 | DRUG DELIVERY DEVICES AND METHODS FOR USE WITH A URINARY CATHETER | TARIS Biomedical LLC (US) | 2020-09-16 | — | — | EP | disclosed |
| US-20200254217-A1 | INTRAVESICAL DRUG DELIVERY DEVICES | MASSACHUSETTS INST TECHNOLOGY (US) | 2020-08-13 | — | — | US | disclosed |
| US-20200254070-A1 | Treatment Of Respiratory Disorders With Arachidonate 15-Lipoxygenase (ALOX15) Inhibitors | REGENERON PHARMACEUTICALS, INC. | 2020-08-13 | — | — | US | disclosed |
| US-10737078-B2 | Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems | TARIS BIOMEDICAL LLC (US) | 2020-08-11 | — | — | US | disclosed |
| US-10729823-B2 | Multi-unit drug delivery devices and methods | TARIS BIOMEDICAL LLC (US) | 2020-08-04 | — | — | US | disclosed |
| EP-3035991-B1 | MULTI-UNIT DRUG DELIVERY DEVICES | TARIS BIOMEDICAL LLC (US) | 2020-07-08 | — | — | EP | disclosed |
| WO-2020139830-A2 | TREATMENT OF RESPIRATORY DISORDERS WITH ARACHIDONATE15-LIPOXYGENASE (ALOX15) INHIBITORS | REGENERON PHARMACEUTICALS, INC. (US) | 2020-07-02 | — | — | WO | disclosed |
| US-20200197310-A1 | Technology for Preparation of Macromolecular Microspheres | NEXBIO, INC. | 2020-06-25 | — | — | US | disclosed |
| US-20200146710-A1 | Scoring Balloon With Translating Scoring Wires | BARD INC C R (US) | 2020-05-14 | — | — | US | disclosed |
| US-10646691-B2 | Intravesical drug delivery methods and devices | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-05-12 | — | — | US | disclosed |
| US-20200113817-A1 | INTRAVESICAL DRUG DELIVERY DEVICE WITH RETENTION FRAME AND DRUG TABLETS | JANSSEN BIOTECH, INC. | 2020-04-16 | — | — | US | disclosed |
| US-20200101009-A1 | ORAL FILM COMPOSITIONS AND DOSAGE FORMS HAVING PRECISE ACTIVE DISSOLUTION PROFILES | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION | 2020-04-02 | — | — | US | disclosed |
| US-20200078044-A1 | SCORING BALLOON WITH TRANSLATING SCORING WIRES | BARD INC C R (US) | 2020-03-12 | — | — | US | disclosed |
| US-10583086-B2 | Technology for preparation of macromolecular microspheres | ANSUN BIOPHARMA, INC. (US) | 2020-03-10 | — | — | US | disclosed |
| US-10561438-B2 | Scoring balloon with translating scoring wires | C.R. BARD, INC. (US) | 2020-02-18 | — | — | US | disclosed |
| US-10543166-B2 | Implantable drug delivery devices and methods of making the same | TARIS BIOMEDICAL LLC (US) | 2020-01-28 | — | — | US | disclosed |
| EP-3562416-A1 | SCORING BALLOON WITH TRANSLATING SCORING WIRES | C.R. Bard, Inc. (US) | 2019-11-06 | — | — | EP | disclosed |
| CN-110418658-A | The method of vivo drug delivery device and drug delivery | TARIS BIOMEDICAL LLC | 2019-11-05 | — | — | CN | disclosed |
| US-20190329011-A1 | DRUG DELIVERY DEVICES WITH DRUG-PERMEABLE COMPONENT AND METHODS | JANSSEN BIOTECH, INC. | 2019-10-31 | — | — | US | disclosed |
| EP-3560443-A1 | SCORING BALLOON WITH TRANSLATING SCORING WIRES | C.R. Bard, Inc. (US) | 2019-10-30 | — | — | EP | disclosed |
| US-20190290415-A1 | TENSION-ADJUSTABLE SURGICAL SLING ASSEMBLY | BOSTON SCIENTIFIC SCIMED, INC. | 2019-09-26 | — | — | US | disclosed |
| EP-3533416-A1 | PELVIC FLOOR REPAIR SYSTEM | Boston Scientific Limited (BM) | 2019-09-04 | — | — | EP | disclosed |
| US-20190249173-A1 | METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS | WAVE LIFE SCIENCES LTD. (SG) | 2019-08-15 | — | — | US | disclosed |
| EP-3367935-B1 | SCORING BALLOON WITH TRANSLATING SCORING WIRES | BARD INC C R (US) | 2019-08-07 | — | — | EP | disclosed |
| US-10369340-B2 | Device and method for sustained release of low water solubility therapeutic agent in solubilizer | NANOMEDICAL SYSTEMS, INC. (US) | 2019-08-06 | — | — | US | disclosed |
| EP-3517099-A1 | INTRAVESICAL DRUG DELIVERY DEVICES AND METHODS INCLUDING ELASTIC POLYMER-DRUG MATRIX SYSTEMS | TARIS Biomedical LLC (US) | 2019-07-31 | — | — | EP | disclosed |
| US-20190201329-A1 | IN VIVO DRUG DELIVERY DEVICES AND METHODS FOR DRUG DELIVERY | JANSSEN BIOTECH, INC. | 2019-07-04 | — | — | US | disclosed |
| EP-2419091-B1 | NANOCHANNELED DEVICE AND RELATED METHODS | UNIV TEXAS (US) | 2019-06-26 | — | — | EP | disclosed |
| US-10315019-B2 | Drug delivery devices with drug-permeable component and methods | TARIS BIOMEDICAL LLC (US) | 2019-06-11 | — | — | US | disclosed |
| US-20190151064-A1 | SYSTEMS, METHODS AND DEVICES RELATING TO IMPLANTABLE SUPPORTIVE SLINGS | BOSTON SCIENTIFIC SCIMED, INC. | 2019-05-23 | — | — | US | disclosed |
| US-10286199-B2 | Drug delivery devices with drug-permeable component and methods | TARIS BIOMEDICAL LLC (US) | 2019-05-14 | — | — | US | disclosed |
| US-10251738-B2 | Pelvic floor repair system | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2019-04-09 | — | — | US | disclosed |
| US-20190083767-A1 | MULTI-LUMEN DRUG DELIVERY DEVICES | TARIS BIOMEDICAL LLC (US) | 2019-03-21 | — | — | US | disclosed |
| US-10231938-B2 | Transdermal drug delivery device including an occlusive backing | NOVEN PHARMACEUTICALS, INC. (US) | 2019-03-19 | — | — | US | disclosed |
| EP-3452597-A1 | METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS | Wave Life Sciences Ltd. (SG) | 2019-03-13 | — | — | EP | disclosed |
| EP-2974692-B1 | PELVIC FLOOR REPAIR SYSTEM | BOSTON SCIENT LTD (BM) | 2019-03-13 | — | — | EP | disclosed |
| CN-109462995-A | The method and composition of bioactivator | 波涛生命科学有限公司 | 2019-03-12 | — | — | CN | disclosed |
| US-10219885-B2 | Systems, methods and devices relating to implantable supportive slings | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2019-03-05 | — | — | US | disclosed |
| EP-3432970-A1 | IN VIVO DRUG DELIVERY DEVICES AND METHODS FOR DRUG DELIVERY | TARIS Biomedical LLC (US) | 2019-01-30 | — | — | EP | disclosed |
| US-10137078-B2 | Methods for intravesical drug delivery and methods and systems for loading devices with drug tablets | TARIS BIOMEDICAL LLC (US) | 2018-11-27 | — | — | US | disclosed |
| US-10137287-B2 | Drug delivery devices and methods for controlled drug release through device orifice | TARIS BIOMEDICAL LLC (US) | 2018-11-27 | — | — | US | disclosed |
| EP-3367935-A1 | SCORING BALLOON WITH TRANSLATING SCORING WIRES | C.R. Bard, Inc. (US) | 2018-09-05 | — | — | EP | disclosed |
| WO-2018144738-A1 | IN VIVO DRUG DELIVERY DEVICES AND METHODS FOR DRUG DELIVERY | TARIS BIOMEDICAL LLC (US) | 2018-08-09 | — | — | WO | disclosed |
| EP-3087949-B1 | SYSTEM RELATING TO IMPLANTABLE SUPPORTIVE SLINGS | BOSTON SCIENT LTD (BM) | 2018-07-25 | — | — | EP | disclosed |
| CN-108289697-A | Scoring balloon with translating score line | 巴德股份有限公司 | 2018-07-17 | — | — | CN | disclosed |
| US-20180185051-A1 | SCORING BALLOON WITH TRANSLATING SCORING WIRES | C.R. BARD, INC. | 2018-07-05 | — | — | US | disclosed |
| WO-2018126014-A1 | SCORING BALLOON WITH TRANSLATING SCORING WIRES | C.R. BARD, INC. (US) | 2018-07-05 | — | — | WO | disclosed |
| US-9999753-B2 | Urological medical devices having a porous membrane for delivery of urologically beneficial agents | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2018-06-19 | — | — | US | disclosed |
| US-20180140748-A1 | DRUG DELIVERY DEVICES AND METHODS | JANSSEN BIOTECH, INC. | 2018-05-24 | — | — | US | disclosed |
| US-20180104455-A1 | ULTRASONIC URINARY BLADDER DRUG DELIVERY | VENSICA MEDICAL LTD. (IL) | 2018-04-19 | — | — | US | disclosed |
| CN-107920904-A | Bracket assembly and method of making a bracket assembly | 南洋理工大学 | 2018-04-17 | — | — | CN | disclosed |
| US-20180071219-A1 | Technology for Preparation of Macromolecular Microspheres | NEXBIO, INC. | 2018-03-15 | — | — | US | disclosed |
| US-20180071213-A1 | INTRAVESICAL DEVICE FOR CONTROLLED DRUG DELIVERY | TARIS BIOMEDICAL, INC. | 2018-03-15 | — | — | US | disclosed |
| EP-3285850-A1 | DRUG DELIVERY DEVICES WITH DRUG-PERMEABLE COMPONENT AND METHODS | TARIS Biomedical LLC (US) | 2018-02-28 | — | — | EP | disclosed |
| US-20180049975-A1 | DRUG DELIVERY DEVICES AND METHODS FOR DRUG DELIVERY | TARIS BIOMEDICAL, INC. | 2018-02-22 | — | — | US | disclosed |
| US-20180042742-A1 | STENT ASSEMBLY AND METHOD OF PREPARING THE STENT ASSEMBLY | SINGAPORE HEALTH SERVICES PTE. LTD. (SG) | 2018-02-15 | — | — | US | disclosed |
| US-20180028449-A1 | Technology for the Preparation of Microparticles | NEXBIO, INC. | 2018-02-01 | — | — | US | disclosed |
| EP-3274044-A1 | ULTRASONIC URINARY BLADDER DRUG DELIVERY | Vensica Medical Ltd. (IL) | 2018-01-31 | — | — | EP | disclosed |
| CN-107614052-A | Ultrasonic wave urinary tract bladder drug delivery | 文斯卡医疗有限公司 | 2018-01-19 | — | — | CN | disclosed |
| US-20180015172-A1 | ENGINEERED RECEPTOR/LIGAND SYSTEM FOR DELIVERY OF THERAPEUTIC AGENTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2018-01-18 | — | — | US | disclosed |
| CN-104546669-B | Nanochannel device and correlation technique | 得克萨斯大学体系董事会 | 2018-01-05 | — | — | CN | disclosed |
| CN-107432979-A | The implantable urinary devices of feature are fetched with improvement | 塔里斯生物医药公司 | 2017-12-05 | — | — | CN | disclosed |
| US-9814671-B2 | Drug delivery devices and methods for drug delivery | TARIS BIOMEDICAL LLC (US) | 2017-11-14 | — | — | US | disclosed |
| WO-2017192679-A1 | METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS | WAVE LIFE SCIENCES LTD. (SG) | 2017-11-09 | — | — | WO | disclosed |
| US-20170319698-A1 | GASTRORETENTIVE GEL FORMULATIONS | JAGOTEC AG (CH) | 2017-11-09 | — | — | US | disclosed |
| US-9801703-B2 | Medical slings | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2017-10-31 | — | — | US | disclosed |
| US-20170290764-A1 | SOLID DRUG TABLETS FOR IMPLANTABLE DRUG DELIVERY DEVICES | JANSSEN BIOTECH, INC. | 2017-10-12 | — | — | US | disclosed |
| US-9757546-B2 | Solid drug tablets for implantable drug delivery devices | TARIS BIOMEDICAL LLC (US) | 2017-09-12 | — | — | US | disclosed |
| US-20170252142-A1 | PELVIC FLOOR REPAIR SYSTEM | BOSTON SCIENTIFIC SCIMED, INC. | 2017-09-07 | — | — | US | disclosed |
| EP-3212167-A1 | GASTRORETENTIVE GEL FORMULATIONS | Jagotec AG (CH) | 2017-09-06 | — | — | EP | disclosed |
| US-20170246437-A1 | pH-MODULATING DRUG DELIVERY DEVICES AND METHODS | TARIS BIOMEDICAL LLC | 2017-08-31 | — | — | US | disclosed |
| CN-107106484-A | Gastric retention gel preparation | 雅戈泰克股份公司 | 2017-08-29 | — | — | CN | disclosed |
| US-20170216314-A1 | TOPICAL FORMULATIONS | NUVO RESEARCH INC. (CA) | 2017-08-03 | — | — | US | disclosed |
| WO-2017132372-A1 | MULTI-LUMEN DRUG DELIVERY DEVICES | TARIS BIOMEDICAL LLC (US) | 2017-08-03 | — | — | WO | disclosed |
| US-9682043-B2 | Method of preparation of mixed phase co-crystals with active agents | MEDCRYSTALFORMS, LLC (US) | 2017-06-20 | — | — | US | disclosed |
| US-20170165460-A1 | INTRAVESICAL DRUG DELIVERY DEVICES AND METHODS INCLUDING ELASTIC POLYMER-DRUG MATRIX SYSTEMS | TARIS BIOMEDICAL LLC (US) | 2017-06-15 | — | — | US | disclosed |
| US-9675436-B2 | Pelvic floor repair system | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2017-06-13 | — | — | US | disclosed |
| US-20170157360-A1 | INTRAVESICAL DRUG DELIVERY METHODS AND DEVICES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2017-06-08 | — | — | US | disclosed |
| EP-2670398-B1 | IMPLANTABLE DEVICE FOR CONTROLLED RELEASE OF LOW SOLUBILITY DRUG | TARIS BIOMEDICAL LLC (US) | 2017-06-07 | — | — | EP | disclosed |
| US-9655706-B2 | Reinforced mesh for retropubic implants | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2017-05-23 | — | — | US | disclosed |
| US-9642912-B2 | Topical formulations for treating skin conditions | CRESCITA THERAPEUTICS INC. (CA) | 2017-05-09 | — | — | US | disclosed |
| US-20170119428-A1 | Scoring Balloon With Translating Scoring Wires | C.R. BARD, INC. | 2017-05-04 | — | — | US | disclosed |
| WO-2017075502-A1 | SCORING BALLOON WITH TRANSLATING SCORING WIRES | C.R.BARD, INC. (US) | 2017-05-04 | — | — | WO | disclosed |
| EP-3160442-A1 | INTRAVESICAL DRUG DELIVERY DEVICES AND METHODS INCLUDING ELASTIC POLYMER-DRUG MATRIX SYSTEMS | TARIS Biomedical LLC (US) | 2017-05-03 | — | — | EP | disclosed |
| CN-104394845-B | Implantable urological device with improved retrieval features | 塔里斯生物医药公司 | 2017-04-26 | — | — | CN | disclosed |
| US-20170095651-A1 | URETERAL STENT DRUG DELIVERY DEVICE, KIT, AND METHOD | TARIS BIOMEDICAL, INC. | 2017-04-06 | — | — | US | disclosed |
| EP-2097013-B1 | SYSTEMS AND DEVICES FOR TREATING PELVIC FLOOR DISORDERS | BOSTON SCIENT LTD (BM) | 2017-03-29 | — | — | EP | disclosed |
| US-20170079920-A1 | Technology for the Preparation of Microparticles | NEXBIO, INC. | 2017-03-23 | — | — | US | disclosed |
| EP-3142740-A1 | DRUG DELIVERY DEVICES AND METHODS | TARIS Biomedical LLC (US) | 2017-03-22 | — | — | EP | disclosed |
| US-9586035-B2 | Implantable drug delivery device and methods for treatment of the bladder and other body vesicles or lumens | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2017-03-07 | — | — | US | disclosed |
| US-9561353-B2 | Intravesical drug delivery device | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2017-02-07 | — | — | US | disclosed |
| US-9539078-B2 | Systems, devices and methods for treating pelvic floor disorders | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2017-01-10 | — | — | US | disclosed |
| US-9526824-B2 | Nanochanneled device and related methods | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2016-12-27 | — | — | US | disclosed |
| US-20160361525-A1 | INTRAVESICAL DRUG DELIVERY DEVICES | TARIS BIOMEDICAL, INC. | 2016-12-15 | — | — | US | disclosed |
| US-20160339217-A1 | DRUG DELIVERY DEVICES WITH DRUG-PERMEABLE COMPONENT AND METHODS | JANSSEN BIOTECH, INC. | 2016-11-24 | — | — | US | disclosed |
| US-9492266-B2 | Ureteral stent drug delivery device, kit, and method | TARIS BIOMEDICAL LLC (US) | 2016-11-15 | — | — | US | disclosed |
| EP-2355864-B1 | NANOCHANNELED DEVICE AND RELATED METHODS | UNIV TEXAS (US) | 2016-11-09 | — | — | EP | disclosed |
| EP-3087949-A1 | SYSTEMS, METHODS AND DEVICES RELATING TO IMPLANTABLE SUPPORTIVE SLINGS | Boston Scientific Limited (BM) | 2016-11-02 | — | — | EP | disclosed |
| EP-2475354-B1 | IMPLANTABLE DEVICE FOR CONTROLLED DRUG DELIVERY | TARIS BIOMEDICAL LLC (US) | 2016-11-02 | — | — | EP | disclosed |
| WO-2016172704-A1 | DRUG DELIVERY DEVICES WITH DRUG-PERMEABLE COMPONENT AND METHODS | TARIS BIOMEDICAL LLC (US) | 2016-10-27 | — | — | WO | disclosed |
| US-20160310715-A1 | Drug Delivery Devices with Drug-Permeable Component and Methods | TARIS BIOMEDICAL LLC | 2016-10-27 | — | — | US | disclosed |
| US-20160296677-A1 | ENDOPROSTHESES | BOSTON SCIENTIFIC SCIMED, INC. | 2016-10-13 | — | — | US | disclosed |
| US-9457176-B2 | Implantable drug delivery device with bladder retention feature | TARIS BIOMEDICAL LLC (US) | 2016-10-04 | — | — | US | disclosed |
| US-20160279399-A1 | OSMOTIC DRUG DELIVERY DEVICES, KITS, AND METHODS | TARIS BIOMEDICAL, INC. | 2016-09-29 | — | — | US | disclosed |
| WO-2016151595-A1 | ULTRASONIC URINARY BLADDER DRUG DELIVERY | VENSICA MEDICAL LTD. (IL) | 2016-09-29 | — | — | WO | disclosed |
| WO-2016148648-A1 | A STENT ASSEMBLY AND METHOD OF PREPARING THE STENT ASSEMBLY | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2016-09-22 | — | — | WO | disclosed |
| EP-3065807-A1 | OSMOTIC DRUG DELIVERY DEVICES, KITS, AND METHODS | TARIS Biomedical LLC (US) | 2016-09-14 | — | — | EP | disclosed |
| US-20160235675-A1 | Technology for the Preparation of Microparticles | NEXBIO, INC. | 2016-08-18 | — | — | US | disclosed |
| WO-2016118787-A1 | ENGINEERED RECEPTOR/LIGAND SYSTEM FOR DELIVERY OF THERAPEUTIC AGENTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2016-07-28 | — | — | WO | disclosed |
| EP-2543341-B1 | A soft tissue anchor | BOSTON SCIENT LTD (BM) | 2016-07-20 | — | — | EP | disclosed |
| EP-1807033-B1 | TRANSDERMAL DRUG DELIVERY DEVICE INCLUDING AN OCCLUSIVE BACKING | NOVEN PHARMA (US) | 2016-07-20 | — | — | EP | disclosed |
| CN-105792880-A | Osmotic drug delivery devices, kits, and methods | 塔里斯生物医药公司 | 2016-07-20 | — | — | CN | disclosed |
| US-20160199544-A1 | MULTI-UNIT DRUG DELIVERY DEVICES AND METHODS | JANSSEN BIOTECH, INC. | 2016-07-14 | — | — | US | disclosed |
| US-20160193456-A1 | Methods for Intravesical Drug Delivery and Methods and Systems for Loading Devices with Drug Tablets | JANSSEN BIOTECH, INC. | 2016-07-07 | — | — | US | disclosed |
| CN-105744983-A | Device and method for sustained release of low water solubility therapeutic agent in solubilizer | 纳米医学系统公司 | 2016-07-06 | — | — | CN | disclosed |
| EP-3035991-A1 | MULTI-UNIT DRUG DELIVERY DEVICES AND METHODS | TARIS Biomedical LLC (US) | 2016-06-29 | — | — | EP | disclosed |
| US-20160175572-A1 | DEVICE AND METHOD FOR SUSTAINED RELEASE OF LOW WATER SOLUBILITY THERAPEUTIC AGENT IN SOLUBILIZER | NANOMEDICAL SYSTEMS, INC. (US) | 2016-06-23 | — | — | US | disclosed |
| EP-3033138-A1 | DEVICE AND METHOD FOR SUSTAINED RELEASE OF LOW WATER SOLUBILITY THERAPEUTIC AGENT IN SOLUBILIZER | Nanomedical Systems Inc. (US) | 2016-06-22 | — | — | EP | disclosed |
| EP-1803415-B1 | Medical implant | BOSTON SCIENT LTD (BB) | 2016-06-01 | — | — | EP | disclosed |
| US-20160128949-A1 | TRANSDERMAL DRUG DELIVERY DEVICE INCLUDING AN OCCLUSIVE BACKING | NOVEN PHARMACEUTICALS, INC. (US) | 2016-05-12 | — | — | US | disclosed |
| WO-2016066256-A1 | GASTRORETENTIVE GEL FORMULATIONS | JAGOTEC AG (CH) | 2016-05-06 | — | — | WO | disclosed |
| US-20160120629-A1 | TENSION-ADJUSTABLE SURGICAL SLING ASSEMBLY | BOSTON SCIENT SCIMED INC (US) | 2016-05-05 | — | — | US | disclosed |
| CN-105530987-A | Multi-unit drug delivery device and method | TARIS BIOMEDICAL INC | 2016-04-27 | — | — | CN | disclosed |
| US-9308181-B2 | Topical formulations, systems and methods | NUVO RESEARCH INC. (CA) | 2016-04-12 | — | — | US | disclosed |
| US-9308162-B2 | Biocompatible oligomer-polymer compositions | TOLMAR THERAPEUTICS, INC. (US) | 2016-04-12 | — | — | US | disclosed |
| US-9308071-B2 | Systems, devices and methods for delivering an implant | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2016-04-12 | — | — | US | disclosed |
| EP-2076209-B1 | PELVIC FLOOR REPAIR IMPLANTS AND METHODS | BOSTON SCIENT SCIMED INC (US) | 2016-03-30 | — | — | EP | disclosed |
| WO-2016040904-A1 | PH-MODULATING DRUG DELIVERY DEVICES AND METHODS | TARIS BIOMEDICAL LLC (US) | 2016-03-17 | — | — | WO | disclosed |
| US-9278134-B2 | Dual functioning ionic liquids and salts thereof | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2016-03-08 | — | — | US | disclosed |
| US-9259517-B2 | Ureteral stent with drug delivery reservoir | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2016-02-16 | — | — | US | disclosed |
| US-9248010-B2 | Tension-adjustable surgical sling assembly | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2016-02-02 | — | — | US | disclosed |
| EP-2968880-A1 | DRUG DELIVERY DEVICES WITH DRUG-PERMEABLE COMPONENT AND METHODS | TARIS Biomedical LLC (US) | 2016-01-20 | — | — | EP | disclosed |
| EP-2968120-A1 | DRUG DELIVERY DEVICES AND METHODS FOR DRUG DELIVERY | TARIS Biomedical LLC (US) | 2016-01-20 | — | — | EP | disclosed |
| EP-2974692-A1 | PELVIC FLOOR REPAIR SYSTEM | Boston Scientific Limited (BM) | 2016-01-20 | — | — | EP | disclosed |
| US-20160008271-A1 | DRUG DELIVERY DEVICES AND METHODS FOR DRUG DELIVERY | TARIS BIOMEDICAL LLC (US) | 2016-01-14 | — | — | US | disclosed |
| EP-2964310-A1 | DRUG DELIVERY DEVICES AND METHODS FOR CONTROLLED DRUG RELEASE THROUGH DEVICE ORIFICE | TARIS Biomedical LLC (US) | 2016-01-13 | — | — | EP | disclosed |
| WO-2015200752-A1 | INTRAVESICAL DRUG DELIVERY DEVICES AND METHODS INCLUDING ELASTIC POLYMER-DRUG MATRIX SYSTEMS | TARIS BIOMEDICAL LLC (US) | 2015-12-30 | — | — | WO | disclosed |
| CN-105209012-A | Drug delivery devices and methods for drug delivery | TARIS BIOMEDICAL INC | 2015-12-30 | — | — | CN | disclosed |
| US-20150366647-A1 | PELVIC FLOOR REPAIR SYSTEM | BOSTON SCIENTIFIC SCIMED, INC. | 2015-12-24 | — | — | US | disclosed |
| US-20150359746-A1 | Technology for the Preparation of Microparticles | NEXBIO, INC. | 2015-12-17 | — | — | US | disclosed |
| US-20150360012-A1 | DRUG DELIVERY DEVICES AND METHODS FOR CONTROLLED DRUG RELEASE THROUGH DEVICE ORIFICE | TARIS BIOMEDICAL, INC. | 2015-12-17 | — | — | US | disclosed |
| CN-105163794-A | Drug delivery device and method with drug permeable member | TARIS BIOMEDICAL INC | 2015-12-16 | — | — | CN | disclosed |
| CN-103379902-B | For the implantable device of the Co ntrolled release of low solubility drug | TARIS BIOMEDICAL, INC. (US) | 2015-11-25 | — | — | CN | disclosed |
| WO-2015175538-A1 | DRUG DELIVERY DEVICES AND METHODS | TARIS BIOMEDICAL LLC (US) | 2015-11-19 | — | — | WO | disclosed |
| EP-2111183-B1 | REINFORCED MESH FOR RETROPUBIC IMPLANTS | BOSTON SCIENT SCIMED INC (US) | 2015-11-18 | — | — | EP | disclosed |
| WO-2015167760-A1 | DRUG DELIVERY VEHICLES COMPRISING CELLULOSE DERIVATIVES, STARCH DERIVATIVES, AND COMBINATIONS THEREOF | CELANESE ACETATE LLC (US) | 2015-11-05 | — | — | WO | disclosed |
| US-20150306230-A1 | DRUG DELIVERY VEHICLES COMPRISING CELLULOSE DERIVATIVES, STARCH DERIVATIVES, AND COMBINATIONS THEREOF | CELANESE ACETATE LLC (US) | 2015-10-29 | — | — | US | disclosed |
| US-20150297723-A1 | TOPICAL FORMULATIONS FOR TREATING SKIN CONDITIONS | NUVO RESEARCH INC. (CA) | 2015-10-22 | — | — | US | disclosed |
| EP-2932939-A1 | Partially soluble implantable or insertable medical devices | Boston Scientific Limited (BM) | 2015-10-21 | — | — | EP | disclosed |
| US-20150290134-A1 | TECHNOLOGY FOR PREPARATION OF MACROMOLECULAR MICROSPHERES | NEXBIO, INC. | 2015-10-15 | — | — | US | disclosed |
| US-9155712-B2 | Transdermal drug delivery device including an occlusive backing | NOVEN PHARMACEUTICALS, INC. (US) | 2015-10-13 | — | — | US | disclosed |
| EP-1909691-B1 | PELVIC FLOOR REPAIR SYSTEM | BOSTON SCIENT LTD (BM) | 2015-09-16 | — | — | EP | disclosed |
| US-9132002-B2 | Pelvic floor repair system | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2015-09-15 | — | — | US | disclosed |
| US-20150246174-A1 | NANOCHANNELED DEVICE AND RELATED METHODS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2015-09-03 | — | — | US | disclosed |
| EP-2912070-A1 | POLYSACCHARIDE ESTER MICROSPHERES AND METHODS AND ARTICLES RELATING THERETO | Celanese Acetate LLC (US) | 2015-09-02 | — | — | EP | disclosed |
| US-9107816-B2 | Implantable device for controlled dissolution and diffusion of low solubility drug | TARIS BIOMEDICAL LLC (US) | 2015-08-18 | — | — | US | disclosed |
| US-9107659-B2 | Snap fit sling anchor system and related methods | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2015-08-18 | — | — | US | disclosed |
| US-20150216649-A1 | SYSTEMS, DEVICES AND METHODS FOR DELIVERING AN IMPLANT | BOSTON SCIENTIFIC SCIMED, INC. | 2015-08-06 | — | — | US | disclosed |
| US-9096743-B2 | Process for forming films, fibers, and beads from chitinous biomass | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2015-08-04 | — | — | US | disclosed |
| US-20150209277-A1 | IMPLANTABLE DEVICE FOR CONTROLLED DRUG DELIVERY | TARIS BIOMEDICAL, INC. | 2015-07-30 | — | — | US | disclosed |
| CN-104812777-A | Polysaccharide ester microspheres and methods and articles related thereto | CELANESE ACETATE LLC | 2015-07-29 | — | — | CN | disclosed |
| US-20150190347-A1 | SOLID DRUG TABLETS FOR IMPLANTABLE DRUG DELIVERY DEVICES | TARIS BIOMEDICAL, INC. | 2015-07-09 | — | — | US | disclosed |
| CN-104758253-A | Technology for preparation of macromolecular microspheres | NEXBIO INC | 2015-07-08 | — | — | CN | disclosed |
| US-20150157578-A1 | TRANSDERMAL DRUG DELIVERY DEVICE INCLUDING AN OCCLUSIVE BACKING | NOVEN PHARMACEUTICALS, INC. (US) | 2015-06-11 | — | — | US | disclosed |
| EP-2881082-A2 | Systems and devices for treating pelvic floor disorders | Boston Scientific Limited (BM) | 2015-06-10 | — | — | EP | disclosed |
| WO-2015069723-A1 | OSMOTIC DRUG DELIVERY DEVICES, KITS, AND METHODS | TARIS BIOMEDICAL LLC (US) | 2015-05-14 | — | — | WO | disclosed |
| US-9022920-B2 | Systems, devices, and methods for sub-urethral support | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2015-05-05 | — | — | US | disclosed |
| US-9022918-B2 | Systems, devices, and methods for delivering an implant | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2015-05-05 | — | — | US | disclosed |
| CN-104546669-A | NANOCHANNELED DEVICE AND RELATED METHODS | UNIV TEXAS | 2015-04-29 | — | — | CN | disclosed |
| US-9017312-B2 | Implantable device for controlled drug delivery | TARIS BIOMEDICAL LLC (US) | 2015-04-28 | — | — | US | disclosed |
| EP-2032076-B1 | PARTIALLY SOLUBLE IMPLANTABLE OR INSERTABLE MEDICAL DEVICES | BOSTON SCIENT LTD (BM) | 2015-04-22 | — | — | EP | disclosed |
| US-9005185-B2 | Nanochanneled device and related methods | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2015-04-14 | — | — | US | disclosed |
| EP-2231254-B9 | IMPLANTABLE DRUG DELIVERY DEVICE | MASSACHUSETTS INST TECHNOLOGY (US) | 2015-04-08 | — | — | EP | disclosed |
| US-20150088150-A1 | IMPLANTABLE UROLOGICAL DEVICE WITH IMPROVED RETRIEVAL FEATURE | TARIS BIOMEDICAL, INC. | 2015-03-26 | — | — | US | disclosed |
| EP-2849725-A1 | IMPLANTABLE UROLOGICAL DEVICE WITH IMPROVED RETRIEVAL FEATURE | Taris Biomedical, Inc. (US) | 2015-03-25 | — | — | EP | disclosed |
| EP-1871282-B1 | SYSTEMS AND DEVICES FOR TREATING PELVIC FLOOR DISORDERS | BOSTON SCIENT LTD (BM) | 2015-03-04 | — | — | EP | disclosed |
| CN-104394845-A | Implantable urological device with improved retrieval features | TARIS BIOMEDICAL INC | 2015-03-04 | — | — | CN | disclosed |
| US-8968182-B2 | Implantable mesh combining biodegradable and non-biodegradable fibers | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2015-03-03 | — | — | US | disclosed |
| WO-2015026813-A1 | MULTI-UNIT DRUG DELIVERY DEVICES AND METHODS | TARIS BIOMEDICAL LLC (US) | 2015-02-26 | — | — | WO | disclosed |
| WO-2015023557-A1 | DEVICE AND METHOD FOR SUSTAINED RELEASE OF LOW WATER SOLUBILITY THERAPEUTIC AGENT IN SOLUBILIZER | NANOMEDICAL SYSTEMS, INC. (US) | 2015-02-19 | — | — | WO | disclosed |
| US-20150050713-A1 | Technology for the Preparation of Microparticles | NEXBIO, INC. | 2015-02-19 | — | — | US | disclosed |
| US-8944989-B2 | Systems, devices, and methods for treating pelvic floor disorders | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2015-02-03 | — | — | US | disclosed |
| EP-2291174-B1 | FLOWABLE COMPOSITION COMPRISING BIOCOMPATIBLE OLIGOMER-POLYMER COMPOSITIONS | TOLMAR THERAPEUTICS INC (US) | 2015-01-28 | — | — | EP | disclosed |
| CN-102271732-B | Nanochannel devices and related methods | UNIV TEXAS | 2014-12-31 | — | — | CN | disclosed |
| US-20140378748-A1 | REINFORCED MESH FOR RETROPUBIC IMPLANTS | BOSTON SCIENTIFIC SCIMED, INC. | 2014-12-25 | — | — | US | disclosed |
| CN-104203220-A | Device and method for sustained release of therapeutic agent | UNIV TEXAS | 2014-12-10 | — | — | CN | disclosed |
| US-8905911-B2 | Surgical slings | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2014-12-09 | — | — | US | disclosed |
| US-20140348936-A1 | GASTRORETENTIVE CONTROLLED RELEASE VEHICLES THAT INCLUDE ETHYLENE COPOLYMERS, ETHYL CELLULOSES, AND/OR THERMOPLASTIC POLYURETHANES | CELANESE EVA PERFORMANCE POLYMERS, INC. | 2014-11-27 | — | — | US | disclosed |
| US-20140350473-A1 | INTRAVESICAL DRUG DELIVERY DEVICE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2014-11-27 | — | — | US | disclosed |
| US-20140328884-A1 | CONTROLLED RELEASE VEHICLES HAVING DESIRED VOID VOLUME ARCHITECTURES | CELANESE EVA PERFORMANCE POLYMERS, INC. | 2014-11-06 | — | — | US | disclosed |
| US-8876691-B2 | Surgical slings | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2014-11-04 | — | — | US | disclosed |
| US-8870745-B2 | Pelvic floor repair implants | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2014-10-28 | — | — | US | disclosed |
| US-20140315720-A1 | POLYSACCHARIDE ESTER MICROSPHERES AND METHODS AND ARTICLES RELATING THERETO | CELANESE ACETATE LLC (US) | 2014-10-23 | — | — | US | disclosed |
| EP-2790678-A1 | GASTRORETENTIVE CONTROLLED RELEASE VEHICLES THAT INCLUDE ETHYLENE COPOLYMERS, ETHYL CELLULOSES, AND/OR THERMPOPLASTIC POLYURETHANES | Celanese Eva Performance Polymers, Inc. (US) | 2014-10-22 | — | — | EP | disclosed |
| EP-2790677-A1 | CONTROLLED RELEASE VEHICLES HAVING DESIRED VOID VOLUME ARCHITECTURES | Celanese Eva Performance Polymers, Inc. (US) | 2014-10-22 | — | — | EP | disclosed |
| US-8858578-B2 | Medical implant | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2014-10-14 | — | — | US | disclosed |
| WO-2014145638-A1 | DRUG DELIVERY DEVICES WITH DRUG-PERMEABLE COMPONENT AND METHODS | TARIS BIOMEDICAL, INC (US) | 2014-09-18 | — | — | WO | disclosed |
| US-20140276636-A1 | DRUG DELIVERY DEVICES WITH DRUG-PERMEABLE COMPONENT AND METHODS | TARIS BIOMEDICAL, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| WO-2014144066-A1 | DRUG DELIVERY DEVICES AND METHODS FOR DRUG DELIVERY | TARIS BIOMEDICAL, INC (US) | 2014-09-18 | — | — | WO | disclosed |
| WO-2014138214-A1 | DRUG DELIVERY DEVICES AND METHODS FOR CONTROLLED DRUG RELEASE THROUGH DEVICE ORIFICE | TARIS BIOMEDICAL, INC. (US) | 2014-09-12 | — | — | WO | disclosed |
| US-8828092-B2 | Reinforced mesh for retropubic implants | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2014-09-09 | — | — | US | disclosed |
| US-20140249362-A1 | IMPLANTABLE MESH COMBINING BIODEGRADABLE AND NON-BIODEGRADABLE FIBERS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2014-09-04 | — | — | US | disclosed |
| EP-2770984-A1 | DEVICE AND METHOD FOR SUSTAINED RELEASE OF THERAPEUTIC AGENT | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-09-03 | — | — | EP | disclosed |
| US-8815281-B2 | Transdermal drug delivery device including an occlusive backing | NOVEN PHARMACEUTICALS, INC. (US) | 2014-08-26 | — | — | US | disclosed |
| US-8801694-B2 | Intravesical drug delivery device | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2014-08-12 | — | — | US | disclosed |
| US-8802596-B2 | Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2014-08-12 | — | — | US | disclosed |
| US-20140221981-A1 | IMPLANTABLE DEVICE WITH INTRAVESICAL TOLERABILITY AND METHODS OF TREATMENT | TARIS BIOMEDICAL, INC. (US) | 2014-08-07 | — | — | US | disclosed |
| US-8777834-B2 | Elastic sling system and related methods | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2014-07-15 | — | — | US | disclosed |
| US-20140180251-A1 | NANOCHANNELED DEVICE AND RELATED METHODS | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2014-06-26 | — | — | US | disclosed |
| US-8753259-B2 | Dissolvable protective treatment for an implantable supportive sling | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2014-06-17 | — | — | US | disclosed |
| EP-1765218-B1 | An implantable sling for treating urinary incontinence | BOSTON SCIENT LTD (BB) | 2014-06-11 | — | — | EP | disclosed |
| US-20140142721-A1 | URETERAL STENT WITH DRUG DELIVERY RESERVOIR | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2014-05-22 | — | — | US | disclosed |
| US-8728169-B2 | Medical apparatuses for delivery of urologically beneficial agents | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2014-05-20 | — | — | US | disclosed |
| US-20140134150-A1 | TECHNOLOGY FOR PREPARATION OF MACROMOLECULAR MICROSPHERES | ANSUN BIOPHARMA, INC. (US) | 2014-05-15 | — | — | US | disclosed |
| CN-103784408-A | Technology for the preparation of microparticles | ANSUN BIOPHARMA INC | 2014-05-14 | — | — | CN | disclosed |
| US-8721519-B2 | Implantable mesh combining biodegradable and non-biodegradable fibers | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2014-05-13 | — | — | US | disclosed |
| EP-2046404-B1 | IMPLANTABLE MESH COMBINING BIODEGRADABLE AND NON-BIODEGRADABLE FIBERS | BOSTON SCIENT SCIMED INC (US) | 2014-05-07 | — | — | EP | disclosed |
| EP-2231254-B1 | IMPLANTABLE DRUG DELIVERY DEVICE | MASSACHUSETTS INST TECHNOLOGY (US) | 2014-05-07 | — | — | EP | disclosed |
| US-20140121454-A1 | SYSTEMS, METHODS AND DEVICES RELATING TO IMPLANTABLE SUPPORTIVE SLINGS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2014-05-01 | — | — | US | disclosed |
| WO-2014066463-A1 | POLYSACCHARIDE ESTER MICROSPHERES AND METHODS AND ARTICLES RELATING THERETO | CELANESE ACETATE LLC (US) | 2014-05-01 | — | — | WO | disclosed |
| US-20140113826-A1 | POLYSACCHARIDE ESTER MICROSPHERES AND METHODS AND ARTICLES RELATING THERETO | CELANESE ACETATE LLC (US) | 2014-04-24 | — | — | US | disclosed |
| US-20140099696-A1 | Technology for the Preparation of Microparticles | ANSUN BIOPHARMA, INC. (US) | 2014-04-10 | — | — | US | disclosed |
| US-8691264-B2 | Implantable or insertable medical devices for controlled drug delivery | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2014-04-08 | — | — | US | disclosed |
| US-8679094-B2 | Implantable device with intravesical tolerability and methods of treatment | TARIS BIOMEDICAL, INC. (US) | 2014-03-25 | — | — | US | disclosed |
| EP-2707074-A1 | MEDICAL APPARATUSES FOR DELIVERY OF UROLOGICALLY BENEFICIAL AGENTS | Boston Scientific Scimed, Inc. (US) | 2014-03-19 | — | — | EP | disclosed |
| CN-102697737-B | Tumor targeting drug loaded particles | AU JESSIE L-S | 2014-03-19 | — | — | CN | disclosed |
| WO-2014031398-A1 | BIOMEDICAL DEVICES COMPRISING MOLDED POLYETHYLENE COMPONENTS | TICONA LLC (US) | 2014-02-27 | — | — | WO | disclosed |
| US-20140051771-A1 | Biomedical Devices Comprising Molded Polyethylene Components | TICONA LLC (US) | 2014-02-20 | — | — | US | disclosed |
| US-20140052264-A1 | Porous, Stabilized Craniomaxillofacial Implants and Methods and Kits Relating Thereto | TICONA LLC (US) | 2014-02-20 | — | — | US | disclosed |
| US-20140031610-A1 | SURGICAL SLINGS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2014-01-30 | — | — | US | disclosed |
| US-8632510-B2 | Nanochanneled device and related methods | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-01-21 | — | — | US | disclosed |
| US-8623419-B2 | Technology for preparation of macromolecular microspheres | ANSUN BIOPHARMA, INC. (US) | 2014-01-07 | — | — | US | disclosed |
| US-20130337031-A1 | TOPICAL FORMULATIONS, SYSTEMS AND METHODS | NUVO RESEARCH INC. (CA) | 2013-12-19 | — | — | US | disclosed |
| EP-2670398-A1 | IMPLANTABLE DEVICE FOR CONTROLLED RELEASE OF LOW SOLUBILITY DRUG | Taris Biomedical, Inc. (US) | 2013-12-11 | — | — | EP | disclosed |
| US-20130324790-A1 | PELVIC FLOOR REPAIR SYSTEM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2013-12-05 | — | — | US | disclosed |
| US-8597367-B2 | Partially soluble implantable or insertable medical devices | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2013-12-03 | — | — | US | disclosed |
| WO-2013177068-A1 | IMPLANTABLE UROLOGICAL DEVICE WITH IMPROVED RETRIEVAL FEATURE | TARIS BIOMEDICAL, INC. (US) | 2013-11-28 | — | — | WO | disclosed |
| US-8591941-B2 | Transdermal drug delivery device including an occlusive backing | NOVEN PHARMACEUTICALS, INC. (US) | 2013-11-26 | — | — | US | disclosed |
| CN-103379902-A | Implantable device for controlled release of low solubility drug | TARIS BIOMEDICAL INC | 2013-10-30 | — | — | CN | disclosed |
| US-8545386-B2 | Surgical slings | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2013-10-01 | — | — | US | disclosed |
| US-20130240483-A1 | NANOCHANNELED DEVICE AND RELATED METHODS | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2013-09-19 | — | — | US | disclosed |
| CN-102481438-B | Implantable drug delivery devices and methods of making the same | TARIS BIOMEDICAL INC | 2013-09-18 | — | — | CN | disclosed |
| US-8535216-B2 | Pelvic floor repair system | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2013-09-17 | — | — | US | disclosed |
| CN-103271083-A | Multi-functional ionic liquid compositions | UNIV ALABAMA | 2013-09-04 | — | — | CN | disclosed |
| US-20130225919-A1 | SYSTEMS, DEVICES AND METHODS FOR TREATING PELVIC FLOOR DISORDERS | BOSTON SCIENTIFIC SCIMED, INC. | 2013-08-29 | — | — | US | disclosed |
| US-8513304-B2 | Topical formulation | NUVO RESEARCH INC. (CA) | 2013-08-20 | — | — | US | disclosed |
| EP-2624875-A1 | TIME-SELECTIVE BIORESORBABLE OR COLLAPSIBLE DRUG DELIVERY SYSTEMS AND METHODS | Taris Biomedical, Inc. (US) | 2013-08-14 | — | — | EP | disclosed |
| US-8480637-B2 | Nanochanneled device and related methods | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-07-09 | — | — | US | disclosed |
| WO-2013090891-A1 | CONTROLLED RELEASE VEHICLES HAVING DESIRED VOID VOLUME ARCHITECTURES | CELANESE EVA PERFORMANCE POLYMERS, INC. (US) | 2013-06-20 | — | — | WO | disclosed |
| US-20130158675-A1 | URETERAL STENT DRUG DELIVERY DEVICE, KIT, AND METHOD | TARIS BIOMEDICAL INC. (US) | 2013-06-20 | — | — | US | disclosed |
| WO-2013090893-A1 | GASTRORETENTIVE CONTROLLED RELEASE VEHICLES THAT INCLUDE ETHYLENE COPOLYMERS, ETHYL CELLULOSES, AND/OR THERMPOPLASTIC POLYURETHANES | CELANESE EVA PERFORMANCE POLYMERS, INC. (US) | 2013-06-20 | — | — | WO | disclosed |
| EP-2600800-A1 | URETERAL STENT DRUG DELIVERY DEVICE, KIT, AND METHOD | Taris Biomedical, Inc. (US) | 2013-06-12 | — | — | EP | disclosed |
| CN-101896221-B | Implantable drug delivery device and methods for treatment of the bladder and other body vestcles or lumens | MASSACHUSETTS INST TECHNOLOGY | 2013-06-05 | — | — | CN | disclosed |
| CN-101326275-B | Multifunctional ionic liquid composition | UNIV ALABAMA | 2013-06-05 | — | — | CN | disclosed |
| US-8454582-B2 | Methods and devices for the treatment of ocular conditions | SURMODICS, INC. (US) | 2013-06-04 | — | — | US | disclosed |
| US-20130129824-A1 | Solid Drug Tablets for Implantable Drug Delivery Devices | TARIS BIOMEDICAL, INC. (US) | 2013-05-23 | — | — | US | disclosed |
| US-20130131628-A1 | DEVICE AND METHOD FOR SUSTAINED RELEASE OF THERAPEUTIC AGENT | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-05-23 | — | — | US | disclosed |
| US-20130116498-A1 | SURGICAL SLINGS | BOSTON SCIENTIFIC SCIMED, INC. | 2013-05-09 | — | — | US | disclosed |
| WO-2013063004-A1 | DEVICE AND METHOD FOR SUSTAINED RELEASE OF THERAPEUTIC AGENT | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-05-02 | — | — | WO | disclosed |
| US-8414914-B2 | Compositions for mucosal delivery of agents | VIRUN, INC. (US) | 2013-04-09 | — | — | US | disclosed |
| US-20130079404-A1 | TOPICAL FORMULATION | NUVO RESEARCH INC. (CA) | 2013-03-28 | — | — | US | disclosed |
| EP-2160208-B1 | MEDICAL BALLOONS AND THE METHODS OF MAKING THE SAME | BOSTON SCIENT SCIMED INC (US) | 2013-03-06 | — | — | EP | disclosed |
| US-20130025781-A1 | FLATTENED TUBULAR MESH SLING AND RELATED METHODS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2013-01-31 | — | — | US | disclosed |
| EP-2068962-B1 | ENDOPROSTHESES | BOSTON SCIENT LTD (BB) | 2013-01-30 | — | — | EP | disclosed |
| EP-2543341-A2 | A soft tissue anchor | Boston Scientific Limited (BB) | 2013-01-09 | — | — | EP | disclosed |
| US-8343962-B2 | Topical formulation | NUVO RESEARCH INC. (CA) | 2013-01-01 | — | — | US | disclosed |
| US-8343516-B2 | Solid drug tablets for implantable drug delivery devices | TARIS BIOMEDICAL, INC. (US) | 2013-01-01 | — | — | US | disclosed |
| US-8337386-B2 | Surgical slings | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-12-25 | — | — | US | disclosed |
| US-20120308644-A1 | Compositions for mucosal delivery of agents | ARCHIMEDES LABORATORIES, INC. | 2012-12-06 | — | — | US | disclosed |
| US-20120302971-A1 | UROLOGICAL MEDICAL DEVICES HAVING A POROUS MEMBRANE FOR DELIVERY OF UROLOGICALLY BENEFICIAL AGENTS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-11-29 | — | — | US | disclosed |
| EP-2445570-B1 | IMPLANTABLE DRUG DELIVERY DEVICES AND METHODS OF MAKING THE SAME | TARIS BIOMEDICAL INC (US) | 2012-11-21 | — | — | EP | disclosed |
| EP-2445571-B1 | SOLID DRUG TABLETS FOR IMPLANTABLE DRUG DELIVERY DEVICES | TARIS BIOMEDICAL INC (US) | 2012-11-21 | — | — | EP | disclosed |
| US-8314077-B2 | Fatty acid-pharmaceutical agent conjugates | LUITPOLD PHARMACEUTICALS, INC. (US) | 2012-11-20 | — | — | US | disclosed |
| WO-2012154946-A1 | MEDICAL APPARATUSES FOR DELIVERY OF UROLOGICALLY BENEFICIAL AGENTS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-11-15 | — | — | WO | disclosed |
| US-20120290100-A1 | MEDICAL APPARATUSES FOR DELIVERY OF UROLOGICALLY BENEFICIAL AGENTS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-11-15 | — | — | US | disclosed |
| EP-2519269-A1 | DRUG-DELIVERY BALLOONS | Boston Scientific Scimed, Inc. (US) | 2012-11-07 | — | — | EP | disclosed |
| US-20120269881-A9 | TRANSDERMAL DRUG DELIVERY DEVICE INCLUDING AN OCCLUSIVE BACKING | NOVEN PHARMACEUTICALS, INC. | 2012-10-25 | — | — | US | disclosed |
| EP-2512581-A1 | IMPLANTABLE DEVICE WITH INTRAVESICAL TOLERABILITY AND METHODS OF TREATMENT | Taris Biomedical, Inc. (US) | 2012-10-24 | — | — | EP | disclosed |
| EP-1933810-B1 | INTRAVESICAL DRUG DELIVERY DEVICE AND METHOD | MASSACHUSETTS INST TECHNOLOGY (US) | 2012-10-10 | — | — | EP | disclosed |
| US-8282542-B2 | Flattened tubular mesh sling and related methods | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-10-09 | — | — | US | disclosed |
| CN-102697737-A | Tumor targeting drug loaded particles | AU JESSIE L-S | 2012-10-03 | — | — | CN | disclosed |
| US-8268352-B2 | Modified release composition for highly soluble drugs | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-18 | — | — | US | disclosed |
| US-20120231047-A1 | THERAPEUTIC AGENT DELIVERY FOR THE TREATMENT OF ASTHMA VIA IMPLANTABLE AND INSERTABLE MEDICAL DEVICES | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-09-13 | — | — | US | disclosed |
| US-8263125-B2 | Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-11 | — | — | US | disclosed |
| US-8252323-B2 | Compositions for mucosal delivery of agents | VIRUN, INC. (US) | 2012-08-28 | — | — | US | disclosed |
| WO-2012106714-A1 | IMPLANTABLE DEVICE FOR CONTROLLED RELEASE OF LOW SOLUBILITY DRUG | TARIS BIOMEDICAL, INC. (US) | 2012-08-09 | — | — | WO | disclosed |
| US-20120203203-A1 | IMPLANTABLE DEVICE FOR CONTROLLED DISSOLUTION AND DIFFUSION OF LOW SOLUBILITY DRUG | TARIS BIOMEDICAL, INC. (US) | 2012-08-09 | — | — | US | disclosed |
| EP-1768647-B1 | COMPOSITIONS COMPRISING A MUCOADHESIVE PROTEIN AND AN ACTIVE PRINCIPLE FOR MUCOSAL DELIVERY OF SAID AGENT | VIRUN INC (US) | 2012-08-08 | — | — | EP | disclosed |
| CN-1816331-B | Tumor targeting drug loaded particles | AU JESSIE L S | 2012-08-08 | — | — | CN | disclosed |
| US-8232265-B2 | Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2012-07-31 | — | — | US | disclosed |
| EP-2475354-A2 | IMPLANTABLE DEVICE FOR CONTROLLED DRUG DELIVERY | Taris Biomedical, Inc. (US) | 2012-07-18 | — | — | EP | disclosed |
| CN-102596174-A | Implantable device for controlled drug delivery | TARIS BIOMEDICAL INC | 2012-07-18 | — | — | CN | disclosed |
| US-20120165762-A1 | TRANSDERMAL DRUG DELIVERY DEVICE INCLUDING AN OCCLUSIVE BACKING | NOVEN PHARMACEUTICALS, INC. | 2012-06-28 | — | — | US | disclosed |
| US-20120150096-A1 | IMPLANTABLE OR INSERTABLE MEDICAL DEVICES FOR CONTROLLED DRUG DELIVERY | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-06-14 | — | — | US | disclosed |
| US-20120141590-A1 | Technology for the Preparation of Microparticles | MALAKHOV MICHAEL (US) | 2012-06-07 | — | — | US | disclosed |
| CN-102481438-A | Implantable Drug Delivery Devices And Methods Of Making The Same | TARIS BIOMEDICAL INC | 2012-05-30 | — | — | CN | disclosed |
| US-20120130156-A1 | SYSTEMS, DEVICES, AND METHODS FOR TREATING PELVIC FLOOR DISORDERS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-05-24 | — | — | US | disclosed |
| CN-102470237-A | Solid drug tablets for implantable drug delivery devices | TARIS BIOMEDICAL INC | 2012-05-23 | — | — | CN | disclosed |
| US-8182464-B2 | Method for intravesical drug delivery | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2012-05-22 | — | — | US | disclosed |
| US-20120115729-A1 | PROCESS FOR FORMING FILMS, FIBERS, AND BEADS FROM CHITINOUS BIOMASS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2012-05-10 | — | — | US | disclosed |
| US-20120116062-A1 | TECHNOLOGY FOR PREPARATION OF MACROMOLECULAR MICROSPHERES | ANSUN BIOPHARMA, INC. | 2012-05-10 | — | — | US | disclosed |
| EP-2445571-A1 | SOLID DRUG TABLETS FOR IMPLANTABLE DRUG DELIVERY DEVICES | Taris Biomedical, Inc. (US) | 2012-05-02 | — | — | EP | disclosed |
| EP-2445570-A1 | IMPLANTABLE DRUG DELIVERY DEVICES AND METHODS OF MAKING THE SAME | Taris Biomedical, Inc. (US) | 2012-05-02 | — | — | EP | disclosed |
| US-20120095443-A1 | NANOCHANNELED DEVICE AND RELATED METHODS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-04-19 | — | — | US | disclosed |
| US-20120089122-A1 | TIME-SELECTIVE BIORESORBABLE OR COLLAPSIBLE DRUG DELIVERY SYSTEMS AND METHODS | TARIS BIOMEDICAL, INC. (US) | 2012-04-12 | — | — | US | disclosed |
| US-20120089121-A1 | Implantable Drug Delivery Device with Bladder Retention Feature | TARIS BIOMEDICAL, INC. (US) | 2012-04-12 | — | — | US | disclosed |
| WO-2012048114-A1 | TIME-SELECTIVE BIORESORBABLE OR COLLAPSIBLE DRUG DELIVERY SYSTEMS AND METHODS | TARIS BIOMEDICAL, INC. (US) | 2012-04-12 | — | — | WO | disclosed |
| WO-2012048104-A1 | IMPLANTABLE DRUG DELIVERY DEVICE WITH BLADDEN RETENTION FEATURE | TARIS BIOMEDICAL, INC. (US) | 2012-04-12 | — | — | WO | disclosed |
| US-8133501-B2 | Relieving pain or discomfort after implantation, including an antiinflammatory agent, an analgesic agent, an anesthetic agent, and an antispasmodic agent with therapeutic agent | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-03-13 | — | — | US | disclosed |
| US-20120053399-A1 | MEDICAL SLINGS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-03-01 | — | — | US | disclosed |
| US-20120046244-A1 | DUAL FUNCTIONING IONIC LIQUIDS AND SALTS THEREOF | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2012-02-23 | — | — | US | disclosed |
| EP-2419091-A2 | NANOCHANNELED DEVICE AND RELATED METHODS | The Board of Regents of The University of Texas System (US) | 2012-02-22 | — | — | EP | disclosed |
| WO-2012019155-A1 | URETERAL STENT DRUG DELIVERY DEVICE, KIT, AND METHOD | TARIS BIOMEDICAL, INC. (US) | 2012-02-09 | — | — | WO | disclosed |
| US-20120016370-A1 | MEDICAL IMPLANT | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-01-19 | — | — | US | disclosed |
| EP-1526880-B1 | IMPLANTABLE OR INSERTABLE MEDICAL DEVICES FOR CONTROLLED DRUG DELIVERY | BOSTON SCIENT LTD (BB) | 2012-01-18 | — | — | EP | disclosed |
| US-20120010462-A1 | SNAP FIT SLING ANCHOR SYSTEM AND RELATED METHODS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-01-12 | — | — | US | disclosed |
| US-20120010721-A1 | PARTIALLY SOLUBLE IMPLANTABLE OR INSERTABLE MEDICAL DEVICES | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-01-12 | — | — | US | disclosed |
| CN-101005828-B | Compositions comprising a mucoadhesive protein and an active principle for mucosal delivery of said agents | VIRUN INC | 2012-01-11 | — | — | CN | disclosed |
| US-20120004500-A1 | SYSTEMS, DEVICES, AND METHODS FOR SUB-URETHRAL SUPPORT | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-01-05 | — | — | US | disclosed |
| US-8057383-B2 | Systems, devices and methods for treating pelvic floor disorders | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-11-15 | — | — | US | disclosed |
| US-8048168-B2 | Partially soluble implantable or insertable medical devices | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-11-01 | — | — | US | disclosed |
| US-8047981-B2 | Medical slings | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-11-01 | — | — | US | disclosed |
| US-20110263932-A1 | PELVIC FLOOR REPAIR IMPLANTS AND METHODS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-10-27 | — | — | US | disclosed |
| US-20110263931-A1 | ELASTIC SLING SYSTEM AND RELATED METHODS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-10-27 | — | — | US | disclosed |
| EP-2068963-B1 | ENDOPROSTHESES | BOSTON SCIENT LTD (BB) | 2011-10-26 | — | — | EP | disclosed |
| CN-102225046-A | Transdermal drug delivery formulation | NUVO RES INC | 2011-10-26 | — | — | CN | disclosed |
| US-8043631-B2 | Tumor targeting drug-loaded particles | AU JESSIE L S | 2011-10-25 | — | — | US | disclosed |
| US-8043205-B2 | Snap fit sling anchor system | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-10-25 | — | — | US | disclosed |
| US-8033982-B2 | Systems, devices and methods relating to a shape resilient sling-like support for treating urinary incontinence | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-10-11 | — | — | US | disclosed |
| US-8033983-B2 | Medical implant | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-10-11 | — | — | US | disclosed |
| US-20110245172-A1 | BIOCOMPATIBLE OLIGOMER-POLYMER COMPOSITIONS | TOLMAR THERAPEUTICS, INC. (US) | 2011-10-06 | — | — | US | disclosed |
| US-8016741-B2 | Systems, devices, and methods for sub-urethral support | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-09-13 | — | — | US | disclosed |
| US-8002821-B2 | Bioerodible metallic ENDOPROSTHESES | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-08-23 | — | — | US | disclosed |
| EP-2355864-A2 | NANOCHANNELED DEVICE AND RELATED METHODS | The Board of Regents of The University of Texas System (US) | 2011-08-17 | — | — | EP | disclosed |
| US-7993390-B2 | Implantable or insertable medical device resistant to microbial growth and biofilm formation | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-08-09 | — | — | US | disclosed |
| US-20110184226-A1 | DISSOLVABLE PROTECTIVE TREATMENT FOR AN IMPLANTABLE SUPPORTIVE SLING | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-07-28 | — | — | US | disclosed |
| WO-2011090569-A1 | DRUG-DELIVERY BALLOONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-07-28 | — | — | WO | disclosed |
| CN-101296691-B | Transdermal drug delivery dosage form | NUVO RES INC | 2011-07-27 | — | — | CN | disclosed |
| US-7985175-B2 | Pelvic floor repair implants and methods | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-07-26 | — | — | US | disclosed |
| US-7981023-B2 | Elastic sling system and related methods | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-07-19 | — | — | US | disclosed |
| US-20110172753-A1 | ENDOPROSTHESES | University of Connecticut, a Connecticut public institution of higher education | 2011-07-14 | — | — | US | disclosed |
| WO-2011084712-A1 | IMPLANTABLE DEVICE WITH INTRAVESICAL TOLERABILITY AND METHODS OF TREATMENT | TARIS BIOMEDICAL, INC. (US) | 2011-07-14 | — | — | WO | disclosed |
| US-7976936-B2 | Endoprostheses | UNIVERSITY OF CONNECTICUT (US) | 2011-07-12 | — | — | US | disclosed |
| US-7976871-B2 | Modified release composition of highly soluble drugs | TORRENT PHARMACEUTICALS LIMITED (IN) | 2011-07-12 | — | — | US | disclosed |
| EP-1898831-B1 | DISSOLVABLE PROTECTIVE TREATMENT FOR AN IMPLANTABLE SUPPORTIVE SLING | BOSTON SCIENT SCIMED LTD (BB) | 2011-07-06 | — | — | EP | disclosed |
| US-20110159073-A1 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR CONDITIONS | DEJUAN EUGENE | 2011-06-30 | — | — | US | disclosed |
| US-20110160659-A1 | Drug-Delivery Balloons | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-06-30 | — | — | US | disclosed |
| US-20110152839-A1 | Implantable Device with Intravesical Tolerability and Methods of Treatment | TARIS BIOMEDICAL, INC. (US) | 2011-06-23 | — | — | US | disclosed |
| US-7951398-B2 | Pharmaceutical preparation comprising an active dispersed on a matrix | NYCOMED GMBH (DE) | 2011-05-31 | — | — | US | disclosed |
| US-20110117184-A1 | Compositions for mucosal delivery of agents | VIRUN, INC. | 2011-05-19 | — | — | US | disclosed |
| US-7942807-B2 | Dissolvable protective treatment for an implantable supportive sling | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-05-17 | — | — | US | disclosed |
| US-20110098526-A1 | PELVIC FLOOR REPAIR SYSTEM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-04-28 | — | — | US | disclosed |
| US-20110097384-A1 | TRANSDERMAL DRUG DELIVERY DEVICE INCLUDING AN OCCLUSIVE BACKING | NOVEN PHARMACEUTICALS, INC. | 2011-04-28 | — | — | US | disclosed |
| US-20110077456-A1 | PROLAPSE REPAIR DEVICE AND METHODS OF USE | DRUMMOND BRUCE | 2011-03-31 | — | — | US | disclosed |
| WO-2011031855-A2 | IMPLANTABLE DEVICE FOR CONTROLLED DRUG DELIVERY | TARIS BIOMEDICAL, INC. (US) | 2011-03-17 | — | — | WO | disclosed |
| US-7906140-B2 | Compositions for mucosal delivery of agents | VIRUN, INC. (US) | 2011-03-15 | — | — | US | disclosed |
| US-20110060309-A1 | Implantable Device for Controlled Drug Delivery | TARIS BIOMEDICAL, INC. (US) | 2011-03-10 | — | — | US | disclosed |
| EP-2291174-A1 | BIOCOMPATIBLE OLIGOMER-POLYMER COMPOSITIONS | Tolmar Therapeutics, Inc. (US) | 2011-03-09 | — | — | EP | disclosed |
| US-20110028460-A1 | TOPICAL FORMULATION | FQUBED, INC. | 2011-02-03 | — | — | US | disclosed |
| US-7878969-B2 | Pelvic floor repair system | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-02-01 | — | — | US | disclosed |
| US-20100330149-A1 | Solid Drug Tablets for Implantable Drug Delivery Devices | TARIS BIOMEDICAL, INC. (US) | 2010-12-30 | — | — | US | disclosed |
| US-20100331770-A1 | Implantable Drug Delivery Devices and Methods of Making the Same | TARIS BIOMEDICAL, INC. (US) | 2010-12-30 | — | — | US | disclosed |
| WO-2010151896-A1 | SOLID DRUG TABLETS FOR IMPLANTABLE DRUG DELIVERY DEVICES | TARIS BIOMEDICAL, INC. (US) | 2010-12-29 | — | — | WO | disclosed |
| WO-2010151893-A1 | IMPLANTABLE DRUG DELIVERY DEVICES AND METHODS OF MAKING THE SAME | TARIS BIOMEDICAL, INC. (US) | 2010-12-29 | — | — | WO | disclosed |
| WO-2010141470-A2 | PROCESS FOR FORMING FILMS, FIBERS, AND BEADS FROM CHITINOUS BIOMASS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2010-12-09 | — | — | WO | disclosed |
| CN-101896221-A | Implantable drug delivery device and methods for treatment of the bladder and other body vestcles or lumens | MASSACHUSETTS INST TECHNOLOGY | 2010-11-24 | — | — | CN | disclosed |
| WO-2010120817-A2 | NANOCHANNELED DEVICE AND RELATED METHODS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-10-21 | — | — | WO | disclosed |
| CN-101848704-A | Techniques for preparing microparticles | NEXBIO INC | 2010-09-29 | — | — | CN | disclosed |
| US-20100234672-A1 | SYSTEMS, DEVICES AND METHODS FOR TREATING PELVIC FLOOR DISORDERS | BOSTON SCIENTIFIC CORPORATION | 2010-09-16 | — | — | US | disclosed |
| WO-2010078300-A1 | DUAL FUNCTIONING IONIC LIQUIDS AND SALTS THEREOF | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2010-07-08 | — | — | WO | disclosed |
| US-20100166874-A1 | Technology for Preparation of Macromolecular Microspheres | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-07-01 | — | — | US | disclosed |
| US-20100152699-A1 | Nanochanneled Device and Related Methods | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-06-17 | — | — | US | disclosed |
| US-20100152704-A1 | Method for Intravesical Drug Delivery | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2010-06-17 | — | — | US | disclosed |
| US-20100145436-A1 | Bio-erodible Stent | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2010-06-10 | — | — | US | disclosed |
| WO-2010056986-A2 | NANOCHANNELED DEVICE AND RELATED METHODS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-05-20 | — | — | WO | disclosed |
| EP-2173327-A2 | TECHNOLOGY FOR THE PREPARATION OF MICROPARTICLES | Nexbio, Inc. (US) | 2010-04-14 | — | — | EP | disclosed |
| EP-2160208-A2 | MEDICAL BALLOONS AND THE METHODS OF MAKING THE SAME | Boston Scientific Scimed, Inc. (US) | 2010-03-10 | — | — | EP | disclosed |
| US-7637860-B2 | Devices for minimally invasive pelvic surgery | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2009-12-29 | — | — | US | disclosed |
| WO-2009148581-A1 | BIOCOMPATIBLE OLIGOMER-POLYMER COMPOSITIONS | QLT USA, INC. (US) | 2009-12-10 | — | — | WO | disclosed |
| EP-2111183-A2 | REINFORCED MESH FOR RETROPUBIC IMPLANTS | Boston Scientific Scimed, Inc. (US) | 2009-10-28 | — | — | EP | disclosed |
| EP-2109477-A2 | CATHETERS AND MEDICAL BALLOONS | Boston Scientific Limited (BB) | 2009-10-21 | — | — | EP | disclosed |
| EP-2104457-A2 | SYSTEMS AND DEVICES FOR DELIVERING AN IMPLANT | Boston Scientific Limited (BB) | 2009-09-30 | — | — | EP | disclosed |
| US-20090240101-A1 | DISSOLVABLE PROTECTIVE TREATMENT FOR AN IMPLANTABLE SUPPORTIVE SLING | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2009-09-24 | — | — | US | disclosed |
| EP-1670381-B1 | SURGICAL SLINGS | BOSTON SCIENT LTD (BB) | 2009-09-23 | — | — | EP | disclosed |
| EP-2097013-A2 | SYSTEMS AND DEVICES FOR TREATING PELVIC FLOOR DISORDERS | Boston Scientific Limited (BB) | 2009-09-09 | — | — | EP | disclosed |
| US-20090187254-A1 | UROLOGICAL MEDICAL DEVICES FOR RELEASE OF UROLOGICALLY BENEFICIAL AGENTS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2009-07-23 | — | — | US | disclosed |
| EP-2076209-A1 | PELVIC FLOOR REPAIR IMPLANTS AND METHODS | Boston Scientific Scimed, Inc. (US) | 2009-07-08 | — | — | EP | disclosed |
| US-7556598-B2 | Dissolvable protective treatment for an implantable supportive sling | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2009-07-07 | — | — | US | disclosed |
| US-20090171465-A1 | Polymeric Regions For Implantable Or Insertable Medical Devices | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2009-07-02 | — | — | US | disclosed |
| US-20090156893-A1 | FLATTENED TUBULAR MESH SLING AND RELATED METHODS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2009-06-18 | — | — | US | disclosed |
| EP-2068781-A2 | MEDICAL DEVICES | Boston Scientific Limited (BB) | 2009-06-17 | — | — | EP | disclosed |
| EP-2068962-A2 | ENDOPROSTHESES | Boston Scientific Limited (BB) | 2009-06-17 | — | — | EP | disclosed |
| EP-2068963-A2 | ENDOPROSTHESES | Boston Scientific Limited (BB) | 2009-06-17 | — | — | EP | disclosed |
| US-20090149833-A1 | Implantable Drug Delivery Device and Methods for Treatment of the Bladder and Other Body Vesicles or Lumens | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2009-06-11 | — | — | US | disclosed |
| EP-1874371-B1 | ENDOPROSTHESES COMPRISING A POLYURETHANE BASED COATING | BOSTON SCIENT LTD (BB) | 2009-05-27 | — | — | EP | disclosed |
| EP-1879578-A4 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE | DOV PHARMACEUTICAL INC (US) | 2009-05-13 | — | — | EP | disclosed |
| EP-1653880-B1 | MEDICAL SLING | BOSTON SCIENT LTD (BB) | 2009-04-29 | — | — | EP | disclosed |
| US-20090098207-A1 | Technology for the Preparation of Microparticles | NEXBIO, INC. (US) | 2009-04-16 | — | — | US | disclosed |
| EP-2046404-A2 | IMPLANTABLE MESH COMBINING BIODEGRADABLE AND NON-BIODEGRADABLE FIBERS | Boston Scientific Scimed, Inc. (US) | 2009-04-15 | — | — | EP | disclosed |
| CN-101404980-A | Preparation Technology of Macromolecular Microspheres | NEXBIO INC (US) | 2009-04-08 | — | — | CN | disclosed |
| US-7513865-B2 | Flattened tubular mesh sling and related methods | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2009-04-07 | — | — | US | disclosed |
| EP-2032076-A1 | PARTIALLY SOLUBLE IMPLANTABLE OR INSERTABLE MEDICAL DEVICES | Boston Scientific Scimed, Inc. (US) | 2009-03-11 | — | — | EP | disclosed |
| WO-2009015286-A2 | TECHNOLOGY FOR THE PREPARATION OF MICROPARTICLES | NEXBIO, INC. (US) | 2009-01-29 | — | — | WO | disclosed |
| WO-2009014793-A2 | MEDICAL BALLOONS AND THE METHODS OF MAKING THE SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2009-01-29 | — | — | WO | disclosed |
| US-20080319092-A1 | Transdermal Drug Delivery Formulation | NUVO RESEARCH INC. (CA) | 2008-12-25 | — | — | US | disclosed |
| CN-101326275-A | Multifunctional ionic liquid composition | UNIV ALABAMA (US) | 2008-12-17 | — | — | CN | disclosed |
| US-20080287984-A1 | Medical balloons and methods of making the same | BOSTON SCIENTIFIC SCIMED, INC. | 2008-11-20 | — | — | US | disclosed |
| US-7445642-B2 | Agent eluting stent and catheter | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2008-11-04 | — | — | US | disclosed |
| CN-101296691-A | transdermal drug delivery dosage form | NUVO RES INC (CA) | 2008-10-29 | — | — | CN | disclosed |
| EP-1981483-A1 | TECHNOLOGY FOR PREPARATION OF MACROMOLECULAR MICROSPHERES | Nexbio, Inc. (US) | 2008-10-22 | — | — | EP | disclosed |
| WO-2008094897-A2 | CATHETERS AND MEDICAL BALLOONS | BOSTON SCIENTIFIC LIMITED (BB) | 2008-08-07 | — | — | WO | disclosed |
| US-20080188825-A1 | Catheters and medical balloons | BOSTON SCIENTIFIC SCIMED, INC. | 2008-08-07 | — | — | US | disclosed |
| WO-2008083394-A2 | REINFORCED MESH FOR RETROPUBIC IMPLANTS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2008-07-10 | — | — | WO | disclosed |
| US-20080161837-A1 | Reinforced mesh for retropubic implants | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2008-07-03 | — | — | US | disclosed |
| EP-1933810-A2 | INTRAVESICAL DRUG DELIVERY DEVICE AND METHOD | Massachusetts Institute of Technology (US) | 2008-06-25 | — | — | EP | disclosed |
| EP-1931760-A2 | MULTI-FUNCTIONAL IONIC LIQUID COMPOSITIONS | The University of Alabama (US) | 2008-06-18 | — | — | EP | disclosed |
| US-20080097349-A1 | Partially soluble implantable or insertable medical devices | BOSTON SCIENTIFIC SCIMED, INC. | 2008-04-24 | — | — | US | disclosed |
| EP-1909691-A1 | PELVIC FLOOR REPAIR SYSTEM | Boston Scientific Scimed, Inc. (US) | 2008-04-16 | — | — | EP | disclosed |
| EP-1909690-A1 | ELASTIC SLING SYSTEM AND RELATED METHODS | Boston Scientific Scimed, Inc. (US) | 2008-04-16 | — | — | EP | disclosed |
| EP-1909687-A1 | SNAP FIT SLING ANCHOR SYSTEM AND RELATED METHODS | Boston Scientific Scimed, Inc. (US) | 2008-04-16 | — | — | EP | disclosed |
| EP-1909772-A1 | TRANSDERMAL DRUG DELIVERY FORMULATION | Nuvo Research Inc. (CA) | 2008-04-16 | — | — | EP | disclosed |
| WO-2008042440-A1 | PELVIC FLOOR REPAIR IMPLANTS AND METHODS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2008-04-10 | — | — | WO | disclosed |
| WO-2008042438-A2 | SYSTEMS AND DEVICES FOR TREATING PELVIC FLOOR DISORDERS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2008-04-10 | — | — | WO | disclosed |
| WO-2008042434-A2 | SYSTEMS AND DEVICES FOR DELIVERING AN IMPLANT | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2008-04-10 | — | — | WO | disclosed |
| US-20080081945-A1 | Pelvic floor repair implants and methods | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2008-04-03 | — | — | US | disclosed |
| US-20080082105-A1 | Systems, devices and methods for treating pelvic floor disorders | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2008-04-03 | — | — | US | disclosed |
| US-20080082121-A1 | Systems, devices, and methods for delivering an implant | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2008-04-03 | — | — | US | disclosed |
| WO-2008036554-A2 | ENDOPROSTHESES | BOSTON SCIENTIFIC LIMITED (BB) | 2008-03-27 | — | — | WO | disclosed |
| WO-2008036548-A2 | ENDOPROSTHESES | BOSTON SCIENTIFIC LIMITED (BB) | 2008-03-27 | — | — | WO | disclosed |
| WO-2008036549-A2 | MEDICAL DEVICES | BOSTON SCIENTIFIC LIMITED (BB) | 2008-03-27 | — | — | WO | disclosed |
| US-20080071358-A1 | ENDOPROSTHESES | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2008-03-20 | — | — | US | disclosed |
| US-20080071350-A1 | ENDOPROSTHESES | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2008-03-20 | — | — | US | disclosed |
| US-20080071349-A1 | Medical Devices | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2008-03-20 | — | — | US | disclosed |
| EP-1898831-A1 | DISSOLVABLE PROTECTIVE TREATMENT FOR AN IMPLANTABLE SUPPORTIVE SLING | BOSTON SCIENTIFIC SCIMED LIMITED (BB) | 2008-03-19 | — | — | EP | disclosed |
| US-20080065201-A1 | Drug-loaded medical device | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2008-03-13 | — | — | US | disclosed |
| US-20080051702-A1 | Therapeutic agent delivery for the treatment of asthma via implantable and insertable medical devices | HERRMANN ROBERT A | 2008-02-28 | — | — | US | disclosed |
| EP-1879578-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE | DOV Pharmaceutical Inc. (US) | 2008-01-23 | — | — | EP | disclosed |
| US-20080009538-A1 | Methods and compositions for the treatment of urinary incontinence | DOV PHARMACEUTICAL, INC. | 2008-01-10 | — | — | US | disclosed |
| EP-1874371-A2 | ENDOPROSTHESES | Boston Scientific Limited (BB) | 2008-01-09 | — | — | EP | disclosed |
| EP-1871282-A1 | SYSTEMS, DEVICES, AND METHODS FOR TREATING PELVIC FLOOR DISORDERS | Boston Scientific Scimed, Inc. (US) | 2008-01-02 | — | — | EP | disclosed |
| EP-1871281-A2 | SYSTEMS, DEVICES, AND METHODS FOR SUB-URETHRAL SUPPORT | Boston Scientific Scimed, Inc. (US) | 2008-01-02 | — | — | EP | disclosed |
| WO-2007149184-A1 | PARTIALLY SOLUBLE IMPLANTABLE OR INSERTABLE MEDICAL DEVICES | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2007-12-27 | — | — | WO | disclosed |
| WO-2007145974-A2 | IMPLANTABLE MESH COMBINING BIODEGRADABLE AND NON-BIODEGRADABLE FIBERS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2007-12-21 | — | — | WO | disclosed |
| US-20070282160-A1 | Implantable mesh combining biodegradable and non-biodegradable fibers | BOSTON SCIENTIFIC SCIMED, INC. | 2007-12-06 | — | — | US | disclosed |
| US-20070269379-A1 | Penetration Enhancer Combinations for Transdermal Delivery | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2007-11-22 | — | — | US | disclosed |
| US-7288084-B2 | Drug-loaded medical device | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2007-10-30 | — | — | US | disclosed |
| US-20070244548-A1 | Sugar-and drug-coated medical device | COOK INCORPORATED (US) | 2007-10-18 | — | — | US | disclosed |
| WO-2007114881-A1 | TECHNOLOGY FOR PREPARATION OF MACROMOLECULAR MICROSPHERES | NEXBIO, INC. (US) | 2007-10-11 | — | — | WO | disclosed |
| WO-2007100459-A2 | SURGICAL SLINGS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2007-09-07 | — | — | WO | disclosed |
| US-20070202151-A1 | INTRAVESICAL DRUG DELIVERY DEVICE AND METHOD | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2007-08-30 | — | — | US | disclosed |
| US-20070190163-A1 | Technology for preparation of macromolecular microspheres | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTE OF HEALTH | 2007-08-16 | — | — | US | disclosed |
| CN-101005828-A | Compositions comprising a mucoadhesive protein and an activeprinciple for mucosal delivery of said agents | VIRUN INC (US) | 2007-07-25 | — | — | CN | disclosed |
| EP-1807033-A2 | TRANSDERMAL DRUG DELIVERY DEVICE INCLUDING AN OCCLUSIVE BACKING | NOVEN PHARMACEUTICALS, INC. (US) | 2007-07-18 | — | — | EP | disclosed |
| WO-2007075636-A2 | FLATENED TUBULAR MESH SLING AND RELATED METHODS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2007-07-05 | — | — | WO | disclosed |
| EP-1803415-A1 | Medical implant | Boston Scientific Limited (BB) | 2007-07-04 | — | — | EP | disclosed |
| US-20070142698-A1 | Flattened tubular mesh sling and related methods | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2007-06-21 | — | — | US | disclosed |
| US-20070123746-A1 | Devices for minimally invasive pelvic surgery | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2007-05-31 | — | — | US | disclosed |
| US-20070122474-A1 | Pharmaceutical preparation comprising an active dispersed on a matrix | ALTANA PHARMA AG | 2007-05-31 | — | — | US | disclosed |
| WO-2007059306-A1 | DEVICE FOR MINIMALLY INVASIVE PELVIC SURGERY | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2007-05-24 | — | — | WO | disclosed |
| US-20070105785-A1 | Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators | DYNOGEN PHARMACEUTICALS, INC. (US) | 2007-05-10 | — | — | US | disclosed |
| US-20070093462-A1 | Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA | 2007-04-26 | — | — | US | disclosed |
| WO-2007044693-A2 | MULTI-FUNCTIONAL IONIC LIQUID COMPOSITIONS | THE UNIVERSITY OF ALABAMA (US) | 2007-04-19 | — | — | WO | disclosed |
| EP-1768647-A1 | COMPOSITIONS COMPRISING A MUCOADHESIVE PROTEIN AND AN ACTIVE PRINCIPLE FOR MUCOSAL DELIVERY OF SAID AGENT | Virun, Inc. (US) | 2007-04-04 | — | — | EP | disclosed |
| EP-1528898-B1 | MEDICAL IMPLANT | BOSTON SCIENT LTD (BB) | 2007-04-04 | — | — | EP | disclosed |
| US-7199151-B2 | DHA-pharmaceutical agent conjugates of taxanes | LUITPOLD PHARMACEUTICALS, INC. (US) | 2007-04-03 | — | — | US | disclosed |
| EP-1765218-A1 | SYSTEMS, METHODS AND DEVICES RELATING TO IMPLANTABLE SUPPORTIVE SLINGS | Boston Scientific Scimed, Inc. (US) | 2007-03-28 | — | — | EP | disclosed |
| US-20070055095-A1 | Pelvic floor repair system | BOSTON SCIENTIFIC SCIMED, INC. | 2007-03-08 | — | — | US | disclosed |
| WO-2007021964-A2 | INTRAVESICAL DRUG DELIVERY DEVICE AND METHOD | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2007-02-22 | — | — | WO | disclosed |
| WO-2007016766-A1 | TRANSDERMAL DRUG DELIVERY FORMULATION | NUVO RESEARCH INC. (CA) | 2007-02-15 | — | — | WO | disclosed |
| WO-2007017019-A2 | ANTIMICROBIAL CATHETERS | MERCK PATENT GMBH (DE) | 2007-02-15 | — | — | WO | disclosed |
| WO-2007018532-A1 | SYSTEMS, DEVICES AND METHODS RELATING TO A SHAPE RESILIENT SLING-LIKE SUPPORT FOR TREATING URINARY INCONTINENCE | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2007-02-15 | — | — | WO | disclosed |
| US-7175854-B2 | Pharmaceutical preparation comprising an active dispersed on a matrix | ALTANA PHARMA AG (DE) | 2007-02-13 | — | — | US | disclosed |
| US-20070032695-A1 | Systems, devices and methods relating to a shape resilient sling-like support for treating urinary incontinence | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2007-02-08 | — | — | US | disclosed |
| WO-2007014240-A1 | ELASTIC SLING SYSTEM AND RELATED METHODS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2007-02-01 | — | — | WO | disclosed |
| WO-2007014241-A1 | PELVIC FLOOR REPAIR SYSTEM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2007-02-01 | — | — | WO | disclosed |
| US-20070021649-A1 | Elastic sling system and related methods | BOSTON SCIENTIFIC SCIMED, INC (US) | 2007-01-25 | — | — | US | disclosed |
| WO-2007011341-A1 | A TENSION-ADJUSTABLE SURGICAL SLING ASSEMBLY | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2007-01-25 | — | — | WO | disclosed |
| US-20070015957-A1 | Tension-adjustable surgical sling assembly | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2007-01-18 | — | — | US | disclosed |
| US-20070015953-A1 | Snap fit sling anchor system and related methods | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2007-01-18 | — | — | US | disclosed |
| WO-2007008209-A1 | SNAP FIT SLING ANCHOR SYSTEM AND RELATED METHODS | BOSTON SCIENTIFIC SCIMED INC. (US) | 2007-01-18 | — | — | WO | disclosed |
| WO-2006102029-A9 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE | DOV PHARMACEUTICAL INC (US) | 2006-12-07 | — | — | WO | disclosed |
| EP-1727583-A1 | AGENT ELUTING STENT AND CATHETER | Boston Scientific Limited (BB) | 2006-12-06 | — | — | EP | disclosed |
| EP-1727520-A2 | METHOD OF PREPARATION OF MIXED PHASE CO-CRYSTALS WITH ACTIVE AGENTS | MEDCRYSTALFORMS, LLC (US) | 2006-12-06 | — | — | EP | disclosed |
| EP-1718348-A2 | IMPLANTABLE OR INSERTABLE MEDICAL DEVICE RESISTANT TO MICROBIAL GROWTH AND BIOFILM FORMATION | Boston Scientific Scimed, Inc. (US) | 2006-11-08 | — | — | EP | disclosed |
| WO-2006115847-A2 | COATED ENDOPROSTHESES | BOSTON SCIENTIFIC LIMITED (BB) | 2006-11-02 | — | — | WO | disclosed |
| US-7125848-B2 | Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators | DYNOGEN PHARMACEUTICALS, INC. (US) | 2006-10-24 | — | — | US | disclosed |
| WO-2006108144-A2 | SYSTEMS, DEVICES, AND METHODS FOR SUB-URETHRAL SUPPORT | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2006-10-12 | — | — | WO | disclosed |
| WO-2006108145-A1 | SYSTEMS, DEVICES, AND METHODS FOR TREATING PELVIC FLOOR DISORDERS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2006-10-12 | — | — | WO | disclosed |
| US-20060229596-A1 | Systems, devices, and methods for treating pelvic floor disorders | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2006-10-12 | — | — | US | disclosed |
| US-20060229493-A1 | Systems, devices, and methods for sub-urethral support | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2006-10-12 | — | — | US | disclosed |
| WO-2006107764-A1 | DISSOLVABLE PROTECTIVE TREATMENT FOR AN IMPLANTABLE SUPPORTIVE SLING | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2006-10-12 | — | — | WO | disclosed |
| US-20060224038-A1 | Dissolvable protective treatment for an implantable supportive sling | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2006-10-05 | — | — | US | disclosed |
| WO-2006102029-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE | DOV PHARMACEUTICAL, INC. (US) | 2006-09-28 | — | — | WO | disclosed |
| US-20060205998-A1 | Surgical slings | BOSTON SCIENTIFIC SCIMED, INC. | 2006-09-14 | — | — | US | disclosed |
| CN-1816331-A | Tumor targeting drug loaded particles | AU JESSIE L S (US) | 2006-08-09 | — | — | CN | disclosed |
| EP-1684661-A1 | MEDICAL SLINGS | Boston Scientific Limited (BB) | 2006-08-02 | — | — | EP | disclosed |
| EP-1670381-A1 | SURGICAL SLINGS | SciMed Life Systems, Inc. (US) | 2006-06-21 | — | — | EP | disclosed |
| US-20060110428-A1 | Methods and devices for the treatment of ocular conditions | SURMODICS MD, LLC | 2006-05-25 | — | — | US | disclosed |
| EP-1653880-A1 | MEDICAL SLING | Boston Scientific Limited (BB) | 2006-05-10 | — | — | EP | disclosed |
| US-7041704-B2 | Methods of treating gastrointestinal tract disorders using sodium channel modulators | DYNOGEN PHARMACEUTICALS, INC. (US) | 2006-05-09 | — | — | US | disclosed |
| US-20060089525-A1 | Systems, methods and devices relating to implantable supportive slings | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2006-04-27 | — | — | US | disclosed |
| WO-2006044206-A2 | TRANSDERMAL DRUG DELIVERY DEVICE INCLUDING AN OCCLUSIVE BACKING | NOVEN PHARMACEUTICALS, INC. (US) | 2006-04-27 | — | — | WO | disclosed |
| US-20060078604-A1 | Transdermal drug delivery device including an occlusive backing | NOVEN PHARMACEUTICALS, INC. | 2006-04-13 | — | — | US | disclosed |
| US-7026360-B1 | Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients | INPHARMA S.A. (CH) | 2006-04-11 | — | — | US | disclosed |
| US-20060034925-A1 | Tumor targeting drug-loaded particles | AU JESSIE L | 2006-02-16 | — | — | US | disclosed |
| WO-2006014484-A2 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR CONDITIONS | SURMODICS, INC. (US) | 2006-02-09 | — | — | WO | disclosed |
| US-20060024365-A1 | Novel dosage form | VAYA NAVIN | 2006-02-02 | — | — | US | disclosed |
| US-20060018933-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | disclosed |
| US-20060018934-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | disclosed |
| WO-2006009825-A1 | COMPOSITIONS COMPRISING A MUCOADHESIVE PROTEIN AND AN ACTIVE PRINCIPLE FOR MUCOSAL DELIVERY OF SAID AGENTS | VIRUN, INC. (US) | 2006-01-26 | — | — | WO | disclosed |
| EP-1617790-A1 | DRUG-LOADED MEDICAL DEVICE | Boston Scientific Scimed, Inc. (US) | 2006-01-25 | — | — | EP | disclosed |
| WO-2005122954-A1 | SYSTEMS, METHODS AND DEVICES RELATING TO IMPLANTABLE SUPPORTIVE SLINGS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2005-12-29 | — | — | WO | disclosed |
| EP-1021204-B1 | BIOADHESIVE COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF ACTIVE AGENTS | NOVEN PHARMA (US) | 2005-12-28 | — | — | EP | disclosed |
| EP-1608359-A2 | TUMOR-TARGETING DRUG-LOADED PARTICLES | AU, Jessie, L.-S. (US) | 2005-12-28 | — | — | EP | disclosed |
| US-20050281772-A1 | Compositions for mucosal delivery of agents | VIRUN, INC. | 2005-12-22 | — | — | US | disclosed |
| EP-1596844-A2 | USE OF SODIUM CHANNEL MODULATORS FOR TREATING GASTROINTESTINAL TRACT DISORDERS | Dynogen Pharmaceuticals Inc. (US) | 2005-11-23 | — | — | EP | disclosed |
| US-20050251249-A1 | Endoprostheses | BOSTON SCIENTIFIC SCIMED, INC. | 2005-11-10 | — | — | US | disclosed |
| EP-1589959-A2 | METHODS OF TREATING LOWER URINARY TRACT DISORDERS USING SODIUM CHANNEL MODULATORS | Dynogen Pharmaceuticals Inc. (US) | 2005-11-02 | — | — | EP | disclosed |
| US-20050234388-A1 | Agent eluting stent and catheter | BOSTON SCIENTIFIC SCIMED, INC. | 2005-10-20 | — | — | US | disclosed |
| WO-2005094930-A1 | AGENT ELUTING STENT AND CATHETER | BOSTON SCIENTIFIC LIMITED (BB) | 2005-10-13 | — | — | WO | disclosed |
| WO-2005087135-A2 | IMPLANTABLE OR INSERTABLE MEDICAL DEVICE RESISTANT TO MICROBIAL GROWTH AND BIOFILM FORMATION | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2005-09-22 | — | — | WO | disclosed |
| US-20050203190-A1 | Methods of treating gastrointestinal tract disorders using sodium channel modulators | DYNOGEN PHARMACEUTICALS, INC. (US) | 2005-09-15 | — | — | US | disclosed |
| US-20050181041-A1 | Method of preparation of mixed phase co-crystals with active agents | MEDCRYSTALFORMS, LLC (US) | 2005-08-18 | — | — | US | disclosed |
| WO-2005055983-A2 | METHOD OF PREPARATION OF MIXED PHASE CO-CRYSTALS WITH ACTIVE AGENTS | MEDCRYSTALFORMS, LLC (US) | 2005-06-23 | — | — | WO | disclosed |
| US-20050113421-A1 | Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating non-inflammatory gastrointestinal tract disorders | DYNOGEN PHARMACEUTICALS, INC. (US) | 2005-05-26 | — | — | US | disclosed |
| US-20050107353-A1 | Methods of treating lower urinary tract disorders using losigamone | DYNOGEN PHARMACEUTICALS, INC. (US) | 2005-05-19 | — | — | US | disclosed |
| EP-1528898-A2 | MEDICAL IMPLANT | Boston Scientific Limited (BB) | 2005-05-11 | — | — | EP | disclosed |
| US-20050096499-A1 | Surgical slings | SCIMED LIFE SYSTEMS, INC (US) | 2005-05-05 | — | — | US | disclosed |
| EP-1526880-A2 | IMPLANTABLE OR INSERTABLE MEDICAL DEVICES FOR CONTROLLED DRUG DELIVERY | SCIMED LIFE SYSTEMS, INC. (US) | 2005-05-04 | — | — | EP | disclosed |
| WO-2005018493-A1 | MEDICAL SLINGS | BOSTON SCIENTIFIC LIMITED (BB) | 2005-03-03 | — | — | WO | disclosed |
| WO-2005018494-A1 | MEDICAL SLINGS | BOSTON SCIENTIFIC LIMITED (BB) | 2005-03-03 | — | — | WO | disclosed |
| WO-2005016184-A1 | SURGICAL SLINGS | SCIMED LIFE SYSTEM, INC. (US) | 2005-02-24 | — | — | WO | disclosed |
| US-20050038452-A1 | Medical slings | SCIMED LIFE SYSTEMS, INC. (US) | 2005-02-17 | — | — | US | disclosed |
| US-20050038451-A1 | Medical slings | SCIMED LIFE SYSTEMS, INC. (US) | 2005-02-17 | — | — | US | disclosed |
| US-20050026835-A1 | Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators | DYNOGEN PHARMACEUTICALS, INC. (US) | 2005-02-03 | — | — | US | disclosed |
| WO-2005009510-A2 | PENETRATION ENHANCER COMBINATIONS FOR TRANSDERMAL DELIVERY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-02-03 | — | — | WO | disclosed |
| US-20050002865-A1 | Diagnostic/therapeutic agents | AMERSHAM HEALTH AS (NO) | 2005-01-06 | — | — | US | disclosed |
| WO-2005000285-A2 | METHODS OF TREATING NON-INFLAMMATORY GASTROINTESTINAL TRACT DISORDERS USING Cav2.2 SUBUNIT CALCIUM CHANNEL MODULATORS | DYNOGEN PHARMACEUTICALS, INC. (US) | 2005-01-06 | — | — | WO | disclosed |
| US-20040249441-A1 | Implantable or insertable medical device resistant to microbial growth and biofilm formation | BOSTON SCIENTIFIC SCIMED, INC. | 2004-12-09 | — | — | US | disclosed |
| CN-1178699-C | Pharmaceutical Compsns. contg. compounds with activity for enhancement of absorption of active ingredients | — | 2004-12-08 | — | — | CN | disclosed |
| WO-2004096096-A1 | DRUG-LOADED MEDICAL DEVICE | SCIMED LIFE SYSTEMS, INC. (US) | 2004-11-11 | — | — | WO | disclosed |
| US-20040215169-A1 | Drug-loaded medical device | SCIMED LIFE SYSTEMS, INC. (US) | 2004-10-28 | — | — | US | disclosed |
| US-20040213842-A1 | Methods of treating gastrointestinal tract disorders using sodium channel modulators | DYNOGEN PHARMACEUTICALS, INC. | 2004-10-28 | — | — | US | disclosed |
| WO-2004089291-A2 | TUMOR-TARGETING DRUG-LOADED PARTICLES | AU JESSIE L-S (US) | 2004-10-21 | — | — | WO | disclosed |
| US-20040209960-A1 | Methods of treating lower urinary tract disorders using sodium channell modulators | DYNOGEN PHARMACEUTICALS, INC. | 2004-10-21 | — | — | US | disclosed |
| EP-1466628-A1 | DHA-pharmaceutical agent conjugates | Luitpold Pharmaceuticals, Inc. (US) | 2004-10-13 | — | — | EP | disclosed |
| US-20040180949-A1 | conjugates of pharmaceutical agents and a highly lipphilic group, a C22 unbranched carbon chain; render the activity of these compounds selective for colon tissue, breast tissue and central nervous system tissue | PROTARGA, INC. | 2004-09-16 | — | — | US | disclosed |
| WO-2004066990-A2 | METHODS OF TREATING LOWER URINARY TRACT DISORDERS USING SODIUM CHANNEL MODULATORS | DYNOGEN PHARMACEUTICALS, INC. (US) | 2004-08-12 | — | — | WO | disclosed |
| WO-2004066987-A2 | USE OF SODIUM CHANNEL MODULATORS FOR TREATING GASTROINTESTINAL TRACT DISORDERS | DYNOGEN PHARMACEUTICALS, INC. (US) | 2004-08-12 | — | — | WO | disclosed |
| US-20040141922-A1 | Diagnostic/therapeutic agents | NYCOMED IMAGING AS | 2004-07-22 | — | — | US | disclosed |
| US-20040106589-A1 | Fatty acid-pharmaceutical agent conjugates | PROTARGA PHARMACEUTICALS, INC. | 2004-06-03 | — | — | US | disclosed |
| US-20040073234-A1 | Medical implant | BOSTON SCIENTIFIC SCIMED, INC. | 2004-04-15 | — | — | US | disclosed |
| US-20040058896-A1 | Pharmaceutical preparation comprising an active dispersed on a matrix | ASTRAZENECA AB (SE) | 2004-03-25 | — | — | US | disclosed |
| WO-2004016180-A2 | MEDICAL IMPLANT | BOSTON SCIENTIFIC LIMITED (BB) | 2004-02-26 | — | — | WO | disclosed |
| WO-2004011055-A2 | IMPLANTABLE OR INSERTABLE MEDICAL DEVICES FOR CONTROLLED DRUG DELIVERY | SCIMED LIFE SYSTEMS, INC. (US) | 2004-02-05 | — | — | WO | disclosed |
| US-20040018241-A1 | Bioadhesive compositions and methods for topical administration of active agents | NOVEN PHARMACEUTICALS, INC. | 2004-01-29 | — | — | US | disclosed |
| US-6680047-B2 | FOR USE IN ULTRASOUND IMAGING, CONTRAST AGENTS | AMERSHAM HEALTH AS (NO) | 2004-01-20 | — | — | US | disclosed |
| US-20030224033-A1 | Implantable or insertable medical devices for controlled drug delivery | BOSTON SCIENTIFIC SCIMED, INC. | 2003-12-04 | — | — | US | disclosed |
| US-6638528-B1 | Pressure-sensitive adhesive matrix comprising blend of polyacrylate, polysiloxane, polyisobutylene, polyisoprene, polyamide or polystyrene; and insoluble, non-adhesive ethyl cellulose; polyvinylpyrrolidone crystallization inhibitor | NOVEN PHARMACEUTICALS, INC. | 2003-10-28 | — | — | US | disclosed |
| EP-1341527-A1 | PHARMACEUTICAL PREPARATION COMPRISING AN ACTIVE DISPERSED ON A MATRIX | ALTANA Pharma AG (DE) | 2003-09-10 | — | — | EP | disclosed |
| US-6602902-B2 | Targeting a pharmaceutical agent to a noncentral nervous system tissue by administering a covalent conjugate of the drug and cis-docosahexanoic acid | PROTARGA, INC. | 2003-08-05 | — | — | US | disclosed |
| EP-1329225-A2 | Transdermal device containing polyvinylpyrrolidone as solubility enhancer | NOVEN PHARMACEUTICALS, INC. (US) | 2003-07-23 | — | — | EP | disclosed |
| US-6576636-B2 | Treating a noncentral nervous system by administering a covalent conjugate of a C8-26, unbranched, naturally occurring fatty acid and a drug, provided the drug is not an adenosine receptor agonist/antagonist; anticarcinogenics | PROTARGA, INC. | 2003-06-10 | — | — | US | disclosed |
| US-6562363-B1 | Bioadhesive compositions and methods for topical administration of active agents | NOVEN PHARMACEUTICALS, INC. | 2003-05-13 | — | — | US | disclosed |
| EP-0737066-B1 | TRANSDERMAL DEVICE CONTAINING POLYVINYLPYRROLIDONE AS SOLUBILITY ENHANCER | NOVEN PHARMA (US) | 2003-04-02 | — | — | EP | disclosed |
| US-20030059471-A1 | Oral delivery formulation | COMPTON BRUCE JON (US) | 2003-03-27 | — | — | US | disclosed |
| US-20020102215-A1 | Diagnostic/therapeutic agents | NYCOMED IMAGING AS | 2002-08-01 | — | — | US | disclosed |
| US-20020102217-A1 | Diagnostic/therapeutic agents | NYCOMED IMAGING AS | 2002-08-01 | — | — | US | disclosed |
| WO-2002045693-A1 | PHARMACEUTICAL PREPARATION COMPRISING AN ACTIVE DISPERSED ON A MATRIX | ALTANA PHARMA AG (DE) | 2002-06-13 | — | — | WO | disclosed |
| US-20020010208-A1 | Targeting a pharmaceutical agent to a noncentral nervous system tissue by administering a covalent conjugate of the drug and cis-docosahexanoic acid | LUITPOLD PHARMACEUTICALS, INC. | 2002-01-24 | — | — | US | disclosed |
| US-20020004065-A1 | Compositions and methods to effect the release profile in the transdermal administration of active agents | KANIOS DAVID (US) | 2002-01-10 | — | — | US | disclosed |
| US-6331289-B1 | ULTRASOUND CONTRAST AGENTS, SUSPENSION IN AQUEOUS CARRIER LIQUID OF A REPORTER COMPRISING GAS-CONTAINING OR GAS-GENERATING MATERIAL, AGENT CAPABLE OF FORMING AT LEAST TWO TYPES OF BINDING PAIRS WITH TARGET; REPORTER BEING CONJUGATED | NYCOMED IMAGING AS (NO) | 2001-12-18 | — | — | US | disclosed |
| US-6264917-B1 | MIXTURE OF GAS FILLED MICROBUBBLES AND RELEASING AGENT | NYCOMED IMAGING AS (NO) | 2001-07-24 | — | — | US | disclosed |
| US-6261537-B1 | TARGETS AND ULTRASOUND DIAGNOSIS OF ACTIVE MATERIALS, AQUEOUS CARRIER LIQUIDS, CARRIERS AND FILM FORMING SURFACTANT PHOSPHATIDES | NYCOMED IMAGING AS (NO) | 2001-07-17 | — | — | US | disclosed |
| US-20010002404-A1 | Fatty acid-pharmaceutical agent conjugates | LUITPOLD PHARMACEUTICALS, INC. | 2001-05-31 | — | — | US | disclosed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | disclosed |
| US-6221383-B1 | BLEND OF AT LEAST TWO POLYMERS, OR AT LEAST ONE POLYMER AND A SOLUBLE POLYVINYLPYRROLIDONE, IN COMBINATION WITH A DRUG PROVIDES A PRESSURE-SENSITIVE ADHESIVE COMPOSITION FOR A TRANSDERMAL DRUG DELIVERY SYSTEM | NOVEN PHARMACEUTICALS, INC. | 2001-04-24 | — | — | US | disclosed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | disclosed |
| US-6183461-B1 | Method for delivering a medication | SITUS CORPORATION | 2001-02-06 | — | — | US | disclosed |
| US-6171298-B1 | Intravesical infuser | SITUS CORPORATION | 2001-01-09 | — | — | US | disclosed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | disclosed |
| EP-1028773-A1 | INTRAVESICAL INFUSER | Situs Corporation (US) | 2000-08-23 | — | — | EP | disclosed |
| EP-1021204-A2 | BIOADHESIVE COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF ACTIVE AGENTS | NOVEN PHARMACEUTICALS, INC. (US) | 2000-07-26 | — | — | EP | disclosed |
| US-6024976-A | TRANSDERMAL DRUG DELIVERY WITH PRESSURE SENSITIVE ADHESIVE COMPOSITION OF POLYVINYLPYRROLIDONE WITH DRUG IN MULTILAYER PATCH | NOVEN PHARMACEUTICALS, INC. (US) | 2000-02-15 | — | — | US | disclosed |
| WO-1999030690-A1 | ORAL DELIVERY FORMULATION | AXIA THERAPEUTICS, INC. (US) | 1999-06-24 | — | — | WO | disclosed |
| WO-1999024106-A1 | INTRAVESICAL INFUSER | SITUS CORPORATION (US) | 1999-05-20 | — | — | WO | disclosed |
| EP-0909183-A2 | DHA-PHARMACEUTICAL AGENT CONJUGATES | Neuromedica, Inc. (US) | 1999-04-21 | — | — | EP | disclosed |
| WO-1999015210-A2 | BIOADHESIVE COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF ACTIVE AGENTS | NOVEN PHARMACEUTICALS, INC. (US) | 1999-04-01 | — | — | WO | disclosed |
| US-5795909-A | ANTICARCINOGENIC AND ANTITUMOR AGENTS; BREAST, COLON, OVARIANCANCERS | NEUROMEDICA, INC. (US) | 1998-08-18 | — | — | US | disclosed |
| WO-1997044063-A2 | DHA-PHARMACEUTICAL AGENT CONJUGATES | NEUROMEDICA, INC. (US) | 1997-11-27 | — | — | WO | disclosed |
| US-5656286-A | BLEND OF TWO POLYMERS; PRESSURE SENSITIVE ADHESIVE | NOVEN PHARMACEUTICALS, INC. (US) | 1997-08-12 | — | — | US | disclosed |
| WO-1996040084-A1 | COMPOSITIONS AND METHODS FOR USE OF PRESSURE SENSITIVE ADHESIVE TRANSDERMAL DEVICES CONTAINING A BIOADHESIVE HUMECTANT | NOVEN PHARMACEUTICALS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| EP-0737066-A1 | TRANSDERMAL DEVICE CONTAINING POLYVINYLPYRROLIDONE AS SOLUBILITY ENHANCER | NOVEN PHARMACEUTICALS, INC. (US) | 1996-10-16 | — | — | EP | disclosed |
| WO-1995018603-A1 | TRANSDERMAL DEVICE CONTAINING POLYVINYLPYRROLIDONE AS SOLUBILITY ENHANCER | NOVEN PHARMACEUTICALS, INC. (US) | 1995-07-13 | — | — | WO | disclosed |
| WO-1995018603-A1 | TRANSDERMAL DEVICE CONTAINING POLYVINYLPYRROLIDONE AS SOLUBILITY ENHANCER | NOVEN PHARMACEUTICALS, INC. (US) | 1995-07-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (36 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150306230-A1 | DRUG DELIVERY VEHICLES COMPRISING CELLULOSE DERIVATIVES, STARCH DERIVATIVES, AND COMBINATIONS THEREOF | PGRMC2, PGRMC1, CYP3A43 | CHRNA7 1911/4885CHRNB4 1838/4885CHRNA3 2129/4885 |
| US-20040141922-A1 | Diagnostic/therapeutic agents | BID, FUS, FABP1 | CHRNA7 4780/4885CHRNB4 4457/4885CHRNA3 4792/4885 |
| US-20110245172-A1 | BIOCOMPATIBLE OLIGOMER-POLYMER COMPOSITIONS | BMP2, CHERP, PUF60 | CHRNA7 3203/4885CHRNB4 3183/4885CHRNA3 3846/4885 |
| US-20070093462-A1 | Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients | SLC5A6, PNLIP, IPMK | CHRNA7 2637/4885CHRNB4 3130/4885CHRNA3 2591/4885 |
| US-20020010208-A1 | Targeting a pharmaceutical agent to a noncentral nervous system tissue by administering a covalent conjugate of the drug and cis-docosahexanoic acid | FABP7, FADS2, ALOX5 | CHRNA7 382/4885CHRNB4 480/4885CHRNA3 319/4885 |
| US-20260021224-A1 | Multi-Unit Drug Delivery Devices and Methods | UROD, SLC14A1, UTS2R | CHRNA7 4017/4885CHRNB4 4140/4885CHRNA3 4505/4885 |
| US-20050113421-A1 | Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating non-inflammatory gastrointestinal tract disorders | TRPV2, RYR2, VDAC2 | CHRNA7 1856/4885CHRNB4 2810/4885CHRNA3 1711/4885 |
| US-20070105785-A1 | Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators | CACNB2, RYR2, FABP2 | CHRNA7 522/4885CHRNB4 593/4885CHRNA3 379/4885 |
| US-20210128511-A1 | PRODRUG COMPOSITIONS AND METHODS OF TREATMENT | ADRA2C, ADRB3, ADRA2B | CHRNA7 313/4885CHRNB4 280/4885CHRNA3 411/4885 |
| US-20230277448-A1 | CHEWABLE FORMULATIONS | SI, TAS2R39, TAS2R31 | CHRNA7 811/4885CHRNB4 2220/4885CHRNA3 2024/4885 |
| US-20050002865-A1 | Diagnostic/therapeutic agents | FUS, HNRNPF, HNRNPR | CHRNA7 4861/4885CHRNB4 4720/4885CHRNA3 4841/4885 |
| US-20220233471-A1 | PRODRUG COMPOSITIONS AND METHODS OF TREATMENT | CYP2C19, PAICS, CYP2B6 | CHRNA7 1497/4885CHRNB4 1389/4885CHRNA3 1479/4885 |
| US-20050203190-A1 | Methods of treating gastrointestinal tract disorders using sodium channel modulators | SLC10A2, TRPV1, VIPR2 | CHRNA7 414/4885CHRNB4 438/4885CHRNA3 315/4885 |
| US-20210322447-A1 | TRANSDERMAL MICRO-DOSING DELIVERY OF PSYCHEDELICS DERIVATIVES | OPRL1, OPRM1, HTR2A | CHRNA7 43/4885CHRNB4 68/4885CHRNA3 84/4885 |
| US-20010002404-A1 | Fatty acid-pharmaceutical agent conjugates | FABP7, FFAR2, FFAR4 | CHRNA7 923/4885CHRNB4 1106/4885CHRNA3 867/4885 |
| US-20040180949-A1 | conjugates of pharmaceutical agents and a highly lipphilic group, a C22 unbranched carbon chain; render the activity of these compounds selective for colon tissue, breast tissue and central nervous system tissue | ALOX12, FABP2, ALOX15B | CHRNA7 1399/4885CHRNB4 1080/4885CHRNA3 1039/4885 |
| US-20230295617-A1 | METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS | ELOVL6, ELOVL5, ELOVL1 | CHRNA7 4557/4885CHRNB4 4231/4885CHRNA3 4355/4885 |
| US-20080009538-A1 | Methods and compositions for the treatment of urinary incontinence | BPHL, MYOF, NISCH | CHRNA7 92/4885CHRNB4 221/4885CHRNA3 245/4885 |
| US-20130337031-A1 | TOPICAL FORMULATIONS, SYSTEMS AND METHODS | SMURF1, SMURF2, SMS | CHRNA7 2834/4885CHRNB4 2752/4885CHRNA3 1709/4885 |
| US-20050026835-A1 | Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators | CACNB2, RYR2, FABP2 | CHRNA7 522/4885CHRNB4 593/4885CHRNA3 379/4885 |
| US-20040213842-A1 | Methods of treating gastrointestinal tract disorders using sodium channel modulators | SLC10A2, VIPR2, TRPV1 | CHRNA7 398/4885CHRNB4 419/4885CHRNA3 296/4885 |
| US-20260034059-A1 | ORAL FILM COMPOSITIONS AND DOSAGE FORMS HAVING PRECISE ACTIVE DISSOLUTION PROFILES | SORD, SLC6A13, CACNA1A | CHRNA7 449/4885CHRNB4 803/4885CHRNA3 839/4885 |
| US-20050107353-A1 | Methods of treating lower urinary tract disorders using losigamone | LPXN, TRPM5, SLC10A2 | CHRNA7 1876/4885CHRNB4 1535/4885CHRNA3 1380/4885 |
| US-20110028460-A1 | TOPICAL FORMULATION | SPTLC1, SPTSSB, SPTLC3 | CHRNA7 3147/4885CHRNB4 2924/4885CHRNA3 3174/4885 |
| US-20040106589-A1 | Fatty acid-pharmaceutical agent conjugates | FABP7, FFAR2, FFAR4 | CHRNA7 923/4885CHRNB4 1106/4885CHRNA3 867/4885 |
| US-20120046244-A1 | DUAL FUNCTIONING IONIC LIQUIDS AND SALTS THEREOF | SLC6A6, SLC10A2, CLK2 | CHRNA7 3133/4885CHRNB4 4251/4885CHRNA3 3784/4885 |
| US-20150297723-A1 | TOPICAL FORMULATIONS FOR TREATING SKIN CONDITIONS | SMURF1, SGMS1, SMURF2 | CHRNA7 4344/4885CHRNB4 4043/4885CHRNA3 3815/4885 |
| US-20260097102-A1 | Treatment Of Respiratory Disorders With Arachidonate 15-Lipoxygenase (ALOX15) Inhibitors | ALOX15, ALOX15B, ALOX5 | CHRNA7 4574/4885CHRNB4 3535/4885CHRNA3 4384/4885 |
| US-20170216314-A1 | TOPICAL FORMULATIONS | SMURF1, SGMS1, SPTLC1 | CHRNA7 4080/4885CHRNB4 4093/4885CHRNA3 3889/4885 |
| US-20040209960-A1 | Methods of treating lower urinary tract disorders using sodium channell modulators | CACNA1G, CACNA1D, CACNA1B | CHRNA7 419/4885CHRNB4 332/4885CHRNA3 358/4885 |
| US-12576253-B2 | Drug delivery device with intravesical tolerability | ABCB11, SLC6A6, SLC10A2 | CHRNA7 4544/4885CHRNB4 4809/4885CHRNA3 4587/4885 |
| US-20230059204-A1 | TRANSDERMAL MICRO-DOSING DELIVERY OF PHARMACEUTICAL AGENTS | OPRM1, OPRL1, OPRK1 | CHRNA7 39/4885CHRNB4 67/4885CHRNA3 79/4885 |
| US-20190249173-A1 | METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS | ELOVL6, ELOVL5, ELOVL1 | CHRNA7 4657/4885CHRNB4 4330/4885CHRNA3 4468/4885 |
| US-20130079404-A1 | TOPICAL FORMULATION | SPTLC1, SPTLC3, SARAF | CHRNA7 1503/4885CHRNB4 1460/4885CHRNA3 1643/4885 |
| US-20020102215-A1 | Diagnostic/therapeutic agents | BID, FUS, FABP1 | CHRNA7 4750/4885CHRNB4 4397/4885CHRNA3 4735/4885 |
| US-20120115729-A1 | PROCESS FOR FORMING FILMS, FIBERS, AND BEADS FROM CHITINOUS BIOMASS | CHIA, CHIT1, CHI3L1 | CHRNA7 1621/4885CHRNB4 1070/4885CHRNA3 1762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.